Share on Facebook Share on Twitter Email
Answers.com

bipolar disorder

 
Medical Encyclopedia: Bipolar Disorder
 

Definition

Bipolar, or manic-depressive disorder, is a mood disorder that causes radical emotional changes and mood swings, from manic highs to depressive lows. The majority of bipolar individuals experience alternating episodes of mania and depression.

Description

In the United States alone, bipolar disorder afflicts almost two million people at an annual cost of over $45 billion, according to a report by the National Institutes of Mental Health. The average age of onset of bipolar disorder is from adolescence through the early twenties. However, because of the complexity of the disorder, a correct diagnosis can be delayed for several years or more. In a survey of bipolar patients conducted by the National Depressive and Manic Depressive Association (MDMDA), one-half of respondents reported visiting three or more professionals before receiving a correct diagnosis, and over one-third reported a wait of ten years or more before they were correctly diagnosed.

The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), the diagnostic standard for mental health professionals in the United States, defines four separate categories of bipolar disorder: bipolar I, bipolar II, cyclothymia, and bipolar not-otherwisespecified (NOS).

Bipolar I disorder is characterized by manic episodes, the "high" of the manic-depressive cycle. A bipolar patient experiencing mania often has feelings of self-importance, elation, talkativeness, increased sociability, and a desire to embark on goal-oriented activities, coupled with the characteristics of irritability, impatience, impulsiveness, hyperactivity, and a decreased need for sleep. Usually this manic period is followed by a period of depression, although a few bipolar I individuals may not experience a major depressive episode. Mixed states, where both manic or hypomanic symptoms and depressive symptoms occur at the same time, also occur frequently with bipolar I patients (for example, depression with the racing thoughts of mania). Also, dysphoric mania is common (mania characterized by anger and irritability).

Bipolar II disorder is characterized by major depressive episodes alternating with episodes of hypomania, a milder form of mania. Bipolar depression may be difficult to distinguish from a unipolar major depressive episode. Patients with bipolar depression tend to have extremely low energy, retarded mental and physical processes, and more profound fatigue (for example, hypersomnia; a sleep disorder marked by a need for excessive sleep or sleepiness when awake) than unipolar depressives.

Cyclothymia refers to the cycling of hypomanic episodes with depression that does not reach major depressive proportions. A third of patients with cyclothymia will develop bipolar I or II disorder later in life.

A phenomenon known as rapid cycling occurs in up to 20% of bipolar I and II patients. In rapid cycling, manic and depressive episodes must alternate frequently; at least 4 times in 12 months; to meet the diagnostic definition. In some cases of "ultra-rapid cycling," the patient may bounce between manic and depressive states several times within a 24-hour period. This condition is very hard to distinguish from mixed states.

Bipolar NOS is a category for bipolar states that do not clearly fit into the bipolar I, II, or cyclothymia diagnoses.

— Paula Anne Ford-Martin



Search unanswered questions...
Enter a word or phrase...
All Community Q&A Reference topics
Dictionary: bipolar disorder
 

n.

A psychiatric disorder marked by alternating episodes of mania and depression. Also called bipolar illness, manic-depressive illness.


 
Dental Dictionary: bipolar disorder
Top

n

A major mood disorder characterized by alternating periods of mania or elation and depression. Formerly called manic-depressive disorder.

 
Alternative Medicine Encyclopedia: Bipolar Disorder
Top

Definition

Bipolar, or manic-depressive disorder, is a mood disorder that causes radical emotional changes and mood swings, from manic highs to depressive lows. The majority of bipolar individuals experience alternating episodes of mania and depression.

Description

In the United States alone, bipolar disorder afflicts approximately 2.3 million people, and nearly 20% of this population will attempt suicide without effective treatment intervention. The average age at onset of bipolar disorder is from adolescence through the early twenties. However, because of the complexity of the disorder, a correct diagnosis can be delayed for several years or more. In a survey of bipolar patients conducted by the National Depressive and Manic Depressive Association (NDMDA), one-half of respondents reported visiting three or more professionals before receiving a correct diagnosis, and over one-third reported a wait of 10 years or more before they were correctly diagnosed.

The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), the diagnostic standard for mental health professionals in the United States, defines four separate categories of bipolar disorder: bipolar I, bipolar II, cyclothymia, and bipolar not-otherwise-specified (NOS).

Bipolar I disorder is characterized by manic episodes, the "high" of the manic-depressive cycle. A bipolar patient experiencing mania often has feelings of self-importance, elation, talkativeness, increased sociability, and a desire to embark on goal-oriented activities, coupled with the characteristics of irritability, impatience, impulsiveness, hyperactivity, and a decreased need for sleep. Usually this manic period is followed by a period of depression, although a few bipolar I individuals may not experience a major depressive episode. Mixed states, where both manic or hypomanic symptoms and depressive symptoms occur at the same time, also occur frequently with bipolar I patients (for example, depression with racing thoughts of mania). Also, dysphoric mania is common (mania characterized by anger and irritability).

Bipolar II disorder is characterized by major depressive episodes alternating with episodes of hypomania, a milder form of mania. Bipolar depression may be difficult to distinguish from a unipolar major depressive episode. Patients with bipolar depression tend to have extremely low energy, retarded mental and physical processes, and more profound fatigue (for example, hypersomnia; a sleep disorder marked by a need for excessive sleep or sleepiness when awake) than unipolar depressives.

Cyclothymia refers to the cycling of hypomanic episodes with depression that does not reach major depressive proportions. One-third of patients with cyclothymia will develop bipolar I or II disorder later in life.

A phenomenon known as rapid cycling occurs in up to 20% of bipolar I and II patients. In rapid cycling, manic and depressive episodes must alternate frequently, at least four times in 12 months, to meet the diagnostic definition. In some cases of "ultra-rapid cycling," the patient may bounce between manic and depressive states several times within a 24-hour period. This condition is very hard to distinguish from mixed states.

Bipolar NOS is a category for bipolar states that do not clearly fit into the bipolar I, II, or cyclothymia diagnoses.

Causes & Symptoms

The source of bipolar disorder has not been clearly defined. Because two-thirds of bipolar patients have a family history of affective or emotional disorders, researchers have searched for a genetic link to the disorder. Several studies have uncovered a number of possible genetic connections to the predisposition for bipolar disorder. Recent studies emphasize a hereditary connection and early research links several chromosomes, one particularly related to bipolar II, to development of the disorder. A 2003 study found that schizophrenia and bipolar disorder could have similar genetic causes that arise from certain problems with genes associated with myelin development in the central nervous system. (Myelin is a white, fat-like substance that forms a sort of layer or sheath around nerve fibers.)

Another possible biological cause under investigation is the presence of an excessive calcium build-up in the cells of bipolar patients. Also, dopamine and other neurochemical transmitters appear to be implicated in bipolar disorder and these are under intense investigation.

Over one-half of patients diagnosed with bipolar disorder have a history of substance abuse. There is a high rate of association between cocaine abuse and bipolar disorder. Some studies have shown up to 30% of abusers meeting the criteria for bipolar disorder. The emotional and physical highs and lows of cocaine use correspond to the manic depression of the bipolar patient, making the disorder difficult to diagnose.

For some bipolar patients, manic and depressive episodes coincide with seasonal changes. Depressive episodes are typical during winter and fall, and manic episodes are more probable in the spring and summer months.

Symptoms of bipolar depressive episodes include low energy levels, feelings of despair, difficulty concentrating, extreme fatigue, and psychomotor retardation (slowed mental and physical capabilities). Manic episodes are characterized by feelings of euphoria, lack of inhibitions, racing thoughts, diminished need for sleep, talkativeness, risk taking, and irritability. In extreme cases, mania can induce hallucinations and other psychotic symptoms such as grandiose illusions.

Diagnosis

Bipolar disorder usually is diagnosed and treated by a psychiatrist and/or a psychologist with medical assistance. In addition to an interview, several clinical inventories or scales may be used to assess the patient's mental status and determine the presence of bipolar symptoms. These include the Millon Clinical Multiaxial Inventory III (MCMI-III), Minnesota Multiphasic Personality Inventory II (MMPI-2), the Internal State Scale (ISS), the Self-Report Manic Inventory (SRMI), and the Young Mania Rating Scale (YMRS). The tests are verbal and/or written and are administered in both hospital and outpatient settings.

Psychologists and psychiatrists typically use the criteria listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) as a guideline for diagnosis of bipolar disorder and other mental illnesses. DSM-IV describes a manic episode as an abnormally elevated or irritable mood lasting a period of at least one week that is distinguished by at least three of the mania symptoms: inflated self-esteem, decreased need for sleep, talkativeness, racing thoughts, distractibility, increase in goal-directed activity, or excessive involvement in pleasurable activities that have a high potential for painful consequences. If the mood of the patient is irritable and not elevated, four of the symptoms are required.

Although many clinicians find the criteria too rigid, a hypomanic diagnosis requires a duration of at least four days with at least three of the symptoms indicated for manic episodes (four if mood is irritable and not elevated). DSM-IV notes that unlike manic episodes, hypomanic episodes do not cause a marked impairment in social or occupational functioning, do not require hospitalization, and do not have psychotic features. In addition, because hypomanic episodes are characterized by high energy and goal directed activities and often result in a positive outcome, or are perceived in a positive manner by the patient, bipolar II disorder can go undiagnosed.

In late 2001, a study reported at an international psychiatric conference that impulsivity remains a key distinguishing characteristic for bipolar disorder, at least when patients are in manic phases.

Bipolar symptoms often present differently in children and adolescents. Manic episodes in these age groups typically are characterized by more psychotic features than in adults, which may lead to a misdiagnosis of schizophrenia. Children and adolescents also tend toward irritability and aggressiveness instead of elation. Further, symptoms tend to be chronic, or ongoing, rather than acute, or episodic. Bipolar children are easily distracted, impulsive, and hyperactive, which can lead to a misdiagnosis of attention-deficit hyperactivity disorder (ADHD). Furthermore, their aggression often leads to violence, which may be misdiagnosed as a conduct disorder.

Substance abuse, thyroid disease, and use of prescription or over-the-counter medication can mask or mimic the presence of bipolar disorder. In cases of substance abuse, the patient must ordinarily undergo a period of detoxification and abstinence before a mood disorder is diagnosed and treatment begins.

Treatment

Alternative treatments for bipolar disorder generally are considered to be complementary treatments to conventional therapies. General recommendations for controlling bipolar symptoms include maintaining a calm environment, avoiding overstimulation, getting plenty of rest, regular exercise, and proper diet. Psychotherapy and counseling are generally recommended treatments for the disease, whether treated alternatively or allopathically. Psychotherapy, such as cognitive-behavioral therapy, can be a useful tool in helping patients and their families adjust to the disorder and in reducing the risk of suicide. Also, educational counseling is recommended for the patient and family. In fact, a 2003 report revealed that people on medication for bipolar disorder have better results if they also participate in family-focused therapy.

Chinese herbs also may help to soften mood swings. Traditional Chinese medicine (TCM) remedies are prescribed based on the patient's overall constitution and the presentation of symptoms. These remedies can stabilize moods, not just treat swings in mood. A TCM practitioner might recommend a mixture called the Iron Filings Combination (which includes the Chinese herbs asparagus, ophiopogon, fritillaria, arisaema, orange peel, polygala, acorus, forsythia, hoelen, fu-shen, scrophularia, uncaria stem, salvia, and iron filings) to treat certain types of mania in the bipolar patient. There are other formulas for depression. A trained practitioner should guide all of these remedies. Compliance can be better with natural remedies if they work. These remedies do not flatten moods and people in manic states do not like to be suppressed.

Acupuncture can be used for treatment to help maintain a more even temperament.

Biofeedback is effective in helping some patients control symptoms such as irritability, poor self control, racing thoughts, and sleep problems. A diet low in vanadium (a mineral found in meats and other foods) and high in vitamin C may be helpful in reducing depression.

In 2003, a report stated that rhythm therapy, or simply taking steps to go to bed and wake up at consistent times each day, helps some people with bipolar disorder maintain mood stability, especially when faced with psychosocial stress.

Recommended herbal remedies to ease depressive episodes may include damiana (Turnera diffusa), ginseng (Panax ginseng), kola (Cola nitida), lady's slipper (Cypripedium calceolus), lavender (Lavandula angustifolia), lime blossom (Tilia x vulgaris), oats (Avena sativa), rosemary (Rosmarinus officinalis), skullcap (Scutellaria laterifolia), St. John's wort (Hypericum perforatum), valerian (Valeriana officinalis), and vervain (Verbena officinalis).

Allopathic Treatment

Allopathic treatment of bipolar disorder is usually by means of medication. A combination of mood stabilizing agents with antidepressants, antipsychotics, and anticonvulsants is used to regulate manic and depressive episodes.

Mood stabilizing agents such as lithium, carbamazepine, and valproate are prescribed to regulate the manic highs and lows of bipolar disorder:

  • Lithium (Cibalith-S, Eskalith, Lithane, Lithobid, Lithonate, Lithotabs) is one of the oldest and most frequently prescribed drugs available for the treatment of bipolar mania and depression. Lithium has also been shown to be effective in regulating bipolar depression, but is not recommended for mixed mania. Possible side effects of the drug include weight gain, thirst, nausea and hand tremors. Prolonged lithium use may also cause hyperthyroidism (a disease of the thryoid that is marked by heart palpitations, nervousness, the presence of goiter, sweating, and a wide array of other symptoms).
  • Carbamazepine (Tegretol, Atretol) is an anticonvulsant drug usually prescribed in conjunction with other mood stabilizing agents. The drug is often used to treat bipolar patients who have not responded well to lithium therapy. Blurred vision and abnormal eye movement are two possible side effects of carbamazepine therapy.
  • Valproate (divalproex sodium, or Depakote; valproic acid, or Depakene) is one of the few drugs available that has been proven effective in treating rapid cycling bipolar and mixed states patients. Valproate is prescribed alone or in combination with carbamazepine and/or lithium. Stomach cramps, indigestion, diarrhea, hair loss, appetite loss, nausea, and unusual weight loss or gain are some of the common side effects of valproate.

Because antidepressants may stimulate manic episodes in some bipolar patients, their use is typically short-term. Selective serotonin reuptake inhibitors (SSRIs) or, less often, monoamine oxidase inhibitors (MAOIs) are prescribed for episodes of bipolar depression. Tricyclic antidepressants used to treat unipolar depression may trigger rapid cycling in bipolar patients and are, therefore, not a preferred treatment option for bipolar depression.

Electroconvulsive therapy (ECT), has a high success rate for treating both unipolar and bipolar depression, and mania. However, because of the convenience of drug treatment and the stigma sometimes attached to ECT therapy, ECT usually is employed after all pharmaceutical treatment options have been explored. ECT is given under anesthesia and patients are given a muscle relaxant medication to prevent convulsions. The treatment consists of a series of electrical pulses that move into the brain through electrodes on the patient's head. Although the exact mechanisms behind the success of ECT therapy are not known, it is believed that this electrical current alters the electrochemical processes of the brain, consequently relieving depression. In bipolar patients, ECT often is used in conjunction with drug therapy.

Long-acting benzodiazepines such as clonazepam (Klonapin) and alprazolam (Xanax) are used for rapid treatment of manic symptoms to calm and sedate patients until mania or hypomania have waned and mood stabilizing agents can take effect. Neuroleptics such as chlorpromazine (Thorazine) and haloperidol (Haldol) also are used to control mania while a mood stabilizer such as lithium or valproate takes effect. Clozapine (Clozaril) is an atypical antipsychotic medication used to control manic episodes in patients who have not responded to typical mood stabilizing agents. The drug also has been a useful prophylactic, or preventative treatment, in some bipolar patients.

The treatment rTMS, or repeated transcranial magnetic stimulation, is a relatively new and still experimental treatment for the depressive phase of bipolar disorder. In rTMS, a large magnet is placed on the patient's head and magnetic fields of different frequency are generated to stimulate the left front cortex of the brain. Unlike ECT, rTMS requires no anesthesia and does not induce seizures.

Expected Results

While most patients will show some positive response to treatment, response varies widely, from full recovery to a complete lack of response to all treatments, alternative or allopathic. Drug therapies frequently need adjustment to achieve the maximum benefit for the patient. Bipolar disorder is a chronic recurrent illness in over 90% of those afflicted, and one that requires lifelong observation and treatment after diagnosis. Patients with untreated or inadequately treated bipolar disorder have a suicide rate of 15-25% and a nine-year decrease in life expectancy. With proper treatment, the life expectancy of the bipolar patient will increase by nearly seven years and work productivity increases by 10 years.

Prevention

The ongoing medical management of bipolar disorder is critical to preventing relapse, or recurrence, of manic episodes. Even in carefully controlled treatment programs, bipolar patients may experience recurring episodes of the disorder. Patient education in the form of psychotherapy or self-help groups is crucial for training bipolar patients to recognize signs of mania and depression and to take an active part in their treatment program.

Resources

Books

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press, Inc., 1994.

Whybrow, Peter C. A Mood Apart. New York: Harper Collins, 1997.

Periodicals

Biederman, Joseph A. "Is There a Childhood Form of Bipolar Disorder?" Harvard Mental Health Letter. 13, no. 9 (March 1997): 8.

Bowden, Charles L. "Choosing the Appropriate Therapy for Bipolar Disorder." Medscape Mental Health. 2, no. 8 (1997). http://www.medscape.com.

Bowden, Charles L. "Update on Bipolar Disorder: Epidemiology, Etiology, Diagnosis, and Prognosis." Medscape Mental Health. 2, no. 6 (1997). http://www.medscape.com.

"Family-focused Therapy May Reduce Relapse Rate." Health & Medicine Week (September 29, 2003): 70.

Francis, A., J.P Docherty, and D.A. Kahn. "The Expert Consensus Guideline Series: Treatment of Bipolar Disorder." Journal of Clinical Psychiatry. 57, supplement 12A (November 1996): 1-89.

Sherman, Carl. "Progress in Bipolar Genetics slow, but promising." Clinical Psychiatry News. 29, no. 12 (December 2001): 4.

Sherman, Carl. "Impulsivity a Key Characteristic of Bipolar Disorder." Clinical Psychiatry News. 29, no. 11 (November 2001): 35.

"Schizophrenia and Bipolar Disorder Could Have Similar Genetic Causes." Genomics & Genetics Weekly (September 26, 2003): 85.

Spete, Heidi. "Rhythm Therapy Can Stabilize Bipolar Disorder Patients." Clinical Psychiatry News. (July 2003): 55.

Organizations

American Psychiatric Association (APA). Office of Public Affairs. 1400 K Street NW, Washington, DC 20005. (202) 682-6119. http://www.psych.org/.

National Alliance for the Mentally Ill (NAMI). 200 North Glebe Road, Suite 1015, Arlington, VA 22203-3754. (800) 950-6264. http://www.nami.org.

National Depressive and Manic-Depressive Association (NDMDA). 730 N. Franklin St., Suite 501, Chicago, IL 60610. (800) 826-3632. http://www.ndmda.org.

National Institute of Mental Health (NIMH). 5600 Fishers Lane, Rm. 7C-02, Bethesda, MD 20857. (301) 443-4513. http://www.nimh.nih.gov/.

[Article by: Paula Ford-Martin; Teresa G. Odle]

 
Children's Health Encyclopedia: Bipolar Disorder
Top

Definition

Bipolar, or manic-depressive disorder, is a mood disorder that causes radical emotional changes and mood swings, from manic highs to depressive lows. The majority of bipolar individuals experience alternating episodes of mania and depression.

Description

The Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), the diagnostic standard for mental health professionals in the United States, defines four separate categories of bipolar disorder: bipolar I, bipolar II, cyclothymia, and bipolar not-otherwise-specified (NOS).

Bipolar I disorder is characterized by manic episodes, the "high" of the manic-depressive cycle. A person with bipolar disorder experiencing mania often has feelings of self-importance, elation, talkativeness, increased sociability, and a desire to embark on goal-oriented activities, coupled with the characteristics of irritability, impatience, impulsiveness, hyperactivity, and a decreased need for sleep. Usually this manic period is followed by a period of depression, although a few bipolar I individuals may not experience a major depressive episode. Mixed states, where both manic or hypomanic symptoms and depressive symptoms occur at the same time, also occur frequently with bipolar I patients (for example, depression with the racing thoughts of mania). Also, dysphoric mania is common (mania characterized by anger and irritability).

Bipolar II disorder is characterized by major depressive episodes alternating with episodes of hypomania, a milder form of mania. Bipolar depression may be difficult to distinguish from a unipolar major depressive episode. Patients with bipolar depression tend to have extremely low energy, retarded mental and physical processes, and more profound fatigue (for example, hypersomnia, a sleep disorder marked by a need for excessive sleep or sleepiness when awake) than unipolar depressives.

Cyclothymia refers to the cycling of hypomanic episodes with depression that does not reach major depressive proportions. One third of patients with cyclothymia develop bipolar I or II disorder later in life.

A phenomenon known as rapid cycling occurs in up to 20 percent of bipolar I and II patients. In rapid cycling, manic and depressive episodes must alternate frequently, at least four times in 12 months, to meet the diagnostic definition. In some cases of "ultra-rapid cycling" the patient may bounce between manic and depressive states several times within a 24-hour period. This condition is very hard to distinguish from mixed states.

Bipolar NOS is a category for bipolar states that do not clearly fit into the bipolar I, II, or cyclothymia diagnoses.

Demographics

According to the American Academy of Child and Adolescent Psychiatry, up to one third of American children and adolescents diagnosed with depression develop early onset bipolar disorder. The average age of onset of bipolar disorder is from adolescence through the early twenties. However, because of the complexity of the disorder, a correct diagnosis can be delayed for several years or more. In a survey of bipolar patients conducted by the National Depressive and Manic Depressive Association (MDMDA), one half of respondents reported visiting three or more professionals before receiving a correct diagnosis, and over one third reported waiting ten years or more before they were correctly diagnosed.

Causes and Symptoms

The cause of bipolar disorder had not as of 2004 been clearly defined. Because two thirds of bipolar patients have a family history of affective or emotional disorders, researchers have searched for a genetic link to the disorder. Several studies have uncovered a number of possible genetic connections to the predisposition for bipolar disorder. A 2003 study found that schizophrenia and bipolar disorder could have similar genetic causes that arise from certain problems with genes associated with myelin development in the central nervous system. (Myelin is a white, fat-like substance that forms a sheath around nerve fibers.) Another possible biological cause under investigation is the presence of an excessive calcium build-up in the cells of bipolar patients. Dopamine and other neurochemical transmitters appear to be implicated in bipolar disorder, and these are under investigation as well.

Over one-half of patients diagnosed with bipolar disorder have a history of substance abuse, which may be an issue in adolescent patients. There is a high rate of association between cocaine abuse and bipolar disorder. Some studies have shown up to 30 percent of abusers meet the criteria for bipolar disorder. The emotional and physical highs and lows of cocaine use correspond to the manic depression of the bipolar patient, making the disorder difficult to diagnose.

For some bipolar patients, manic and depressive episodes coincide with seasonal changes. Depressive episodes are typical during winter and fall, and manic episodes are more probable in the spring and summer months.

Symptoms of bipolar depressive episodes include low energy levels, feelings of despair, difficulty concentrating, extreme fatigue, and psychomotor retardation (slowed mental and physical capabilities). Manic episodes are characterized by feelings of euphoria, lack of inhibitions, racing thoughts, diminished need for sleep, talkativeness, risk taking, and irritability. In extreme cases, mania can induce hallucinations and other psychotic symptoms such as grandiose delusions.

When to Call the Doctor

When symptoms of bipolar disorder are present, a child should be taken to a qualified medical healthcare professional as soon as possible for evaluation. If a child or teen diagnosed with bipolar disorder reveals at any time that they have had recent thoughts of self-injury or suicide, or if they demonstrate behavior that compromises their safety or the safety of others, professional assistance from a mental healthcare provider or care facility should be sought immediately.

Diagnosis

Bipolar disorder usually is diagnosed and treated by a psychiatrist and/or a psychologist. In addition to an interview with the child and her parents, several clinical inventories or scales may be used to assess the patient's mental status and determine the presence of bipolar symptoms. These include the Children's Global Assessment Scale (C-GAS), General Behavior Inventory (GBI), Beck Depression Inventory (BDI), Minnesota Multiphasic Personality Inventory Adolescent (MMPI-A), the Youth Inventory (YI-4), and the Young Mania Rating Scale (YMRS). The tests are verbal and/or written and are administered in both hospital and outpatient settings.

Bipolar symptoms often present differently in children and adolescents. Manic episodes in these age groups are typically characterized by more psychotic features than in adults, which may lead to a misdiagnosis of schizophrenia. Children and adolescents also tend to demonstrate irritability and aggressiveness instead of the elation of mania in adults. Further, symptoms tend to be chronic, or ongoing, rather than acute, or episodic. Bipolar children are easily distracted, impulsive, and hyperactive, which can lead to a misdiagnosis of attention deficit hyperactivity disorder (ADHD). Their aggression can lead to violence, which may be misdiagnosed as a conduct disorder.

Psychologists and psychiatrists typically use the criteria listed in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) as a guideline for diagnosis of bipolar disorder and other mental illnesses. DSM-IV describes a manic episode as an abnormally elevated or irritable mood lasting a period of at least one week that is distinguished by at least three of the mania symptoms: inflated self-esteem, decreased need for sleep, talkativeness, racing thoughts, distractibility, increase in goal-directed activity, or excessive involvement in pleasurable activities that have a high potential for painful consequences. If the mood of the patient is irritable and not elevated, four of the symptoms are required.

Although many clinicians find the criteria too rigid, a hypomanic diagnosis requires a duration of at least four days with at least three of the symptoms indicated for manic episodes (four if mood is irritable and not elevated). DSM-IV notes that unlike manic episodes, hypomanic episodes do not cause a marked impairment in social or occupational functioning, do not require hospitalization, and do not have psychotic features. In addition, because hypomanic episodes are characterized by high energy and goal-directed activities and often result in a positive outcome or are perceived in a positive manner by the patient, bipolar II disorder can go undiagnosed.

Substance abuse can mask or mimic the presence of bipolar disorder and can make diagnosis more difficult in adolescents. When substance abuse or addiction is present, a patient must ordinarily undergo a period of detoxification and abstinence before a mood disorder can be accurately diagnosed.

Treatment

The manic and depressive symptoms of bipolar disorder are usually controlled by a combination of prescription medications, including lithium, antipsychotics, anticonvulsants, and antidepressants.

Lithium

Lithium (Cibalith-S, Eskalith, Lithane, Lithobid, Lithonate, Lithotabs) is one of the oldest and most frequently prescribed drugs available for the treatment of adult bipolar mania and depression. Because the drug takes four to ten days to reach a therapeutic level in the bloodstream, it sometimes is prescribed in conjunction with neuroleptics and/or benzodiazepines to provide more immediate relief of a manic episode. Lithium also has been shown to be effective in regulating bipolar depression, but is not recommended for mixed mania. Lithium may not be an effective long-term treatment option for rapid cyclers, who typically develop a tolerance for it, or may not respond to it. Possible side effects of the drug include weight gain, thirst, nausea, and hand tremors. Prolonged lithium use also may cause hyperthyroidism.

Antipsychotics

Clozapine (Clozaril) is an atypical antipsychotic medication used to control manic episodes in adult patients who have not responded to typical mood stabilizing agents. The drug has also been a useful prophylactic, or preventative treatment, in some bipolar patients. Common side effects of clozapine include tachycardia (rapid heart rate), hypotension, constipation, and weight gain. Agranulocytosis, a potentially serious but reversible condition in which the white blood cells that typically fight infection in the body are destroyed, is a possible side effect of clozapine. Patients treated with the drug should undergo weekly blood tests to monitor white blood cell counts.

Risperidone (Risperdal) is another atypical antipsychotic that has been successful in controlling mania in several clinical trials when low doses were administered. The side effects of risperidone are mild compared to many other antipsychotics (constipation, coughing, diarrhea, dry mouth, headache, heartburn, increased length of sleep and dream activity, nausea, runny nose, sore throat, fatigue, and weight gain).

Olanzapine (Zyprexa) was approved in 2003 for use in combination with lithium or valproate for treatment of acute manic episodes associated with bipolar disorder. In 2004 it received additional approval for long-term maintenance of bipolar disorder. Possible side effects include drowsiness, dizziness, weight gain, dry mouth, rapid heartbeat, nausea, and muscle weakness.

Quetiapine (Seroquel) was approved by the FDA in 2004 for the treatment of acute mania associated with bipolar disorder. Potential side effects of the drug include dizziness, sleepiness, dry mouth, weight gain, and constipation.

Ziprasidone (Geodon) is a schizophrenia drug that is often prescribed to treat bipolar mania. Common side effects associated with ziprasidone include dizziness, fatigue, constipation, and rash. Unlike the other antipsychotic drugs, however, it does not promote weight gain.

Atypical antipsychotics have been associated with hyperglycemia (high blood sugar) and diabetes in some patients. Their use may be contraindicated (i.e., not recommended) in children and teens with type 1 or type 2 diabetes.

Anticonvulsants

Valproate (divalproex sodium, or Depakote; valproic acid, or Depakene) is one of the few drugs available that has been proven effective in treating rapid cycling bipolar and mixed states patients. It is also approved for the treatment of mania. Valproate is prescribed alone or in combination with carbamazepine and/or lithium. Stomach cramps, indigestion, diarrhea, hair loss, appetite loss, nausea, and unusual weight loss or gain are some of the common side effects of valproate. A 2003 study found that the risk of suicide from death is about two and one half times higher in people with bipolar disorder taking divalproex than those taking lithium.

Gabapentin (Neurontin) has been prescribed by some physicians for the treatment of bipolar disorder, although there is no conclusive clinical evidence as to its effectiveness.

Carbamazepine (Tegretol, Atretol) is an anticonvulsant drug usually prescribed in conjunction with other mood stabilizing agents. The drug often is used to treat bipolar patients who have not responded well to lithium therapy. Blurred vision and abnormal eye movement are two possible side effects of carbamazepine therapy. Clinical trials continue as of 2004 in an attempt to obtain FDA approval of carbamazepine for use in bipolar treatment.

Lamotrigine (Lamictal, or LTG), an anticonvulsant medication, is often used in patients with a history of rapid cycling and antidepressant-induced mania. A University of Cincinnati one-year study of the drug in patients with bipolar I disorder found that it provided sustained relief of depressive symptoms. Lamotrigine may be used in conjunction with divalproex (divalproate) and/or lithium. Possible side effects of lamotrigine include skin rash, dizziness, drowsiness, headache, nausea, and vomiting.

Antidepressants

Because antidepressants may stimulate manic episodes in some bipolar children and teens, their use is typically short-term. Some researchers have hypothesized that the use of antidepressants for depression may even trigger bipolar disorder in children who are genetically predisposed.

When antidepressants are prescribed for episodes of bipolar depression, they are usually selective serotonin reuptake inhibitors (SSRIs) or, less often, monoamine oxidase inhibitors (MAO inhibitors). Tricyclic antidepressants used to treat unipolar depression may trigger rapid cycling in bipolar patients and are, therefore, not a preferred treatment option for bipolar depression.

SSRIs, such as fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil) regulate depression by regulating levels of serotonin, a neurotransmitter. Anxiety, diarrhea, drowsiness, headache, sweating, nausea, sexual problems, and insomnia are all possible side effects of SSRIs.

MAOIs such as tranylcypromine (Parnate) and phenelzine (Nardil) block the action of monoamine oxidase (MAO), an enzyme in the central nervous system. Patients taking MAOIs must cut foods high in tyramine (found in aged cheeses and meats) out of their diet to avoid hypotensive side effects.

Bupropion (Wellbutrin) is a heterocyclic antidepressant. The exact neurochemical mechanism of the drug is not known, but it has been effective in regulating bipolar depression in some patients. Side effects of bupropion include agitation, anxiety, confusion, tremor, dry mouth, fast or irregular heartbeat, headache, and insomnia.

In 2004, 10 antidepressant drugs (including fluoxetine, sertraline, paroxetine, and bupropion) came under scrutiny when the FDA issued a public health advisory and announced it was requesting the addition of a warning statement in drug labeling that outlined the possibility of worsening depression and increased suicide risk. These developments were the result of several clinical studies that found that some children taking these antidepressants had an increased risk of suicidal thoughts and actions. The FDA announced at the time that the agency would embark on a more extensive analysis of the data from these clinical trials and decide if further regulatory action was necessary.

Electroconvulsive Therapy

Electroconvulsive therapy (ECT) has a high success rate for treating both unipolar and bipolar depression and mania. However, because of the convenience of drug treatment and the stigma sometimes attached to ECT therapy, ECT usually is employed after all pharmaceutical treatment options have been explored. ECT is given under anesthesia, and patients are given a muscle relaxant medication to prevent convulsions. The treatment consists of a series of electrical pulses that move into the brain through electrodes on the patient's head. Although the exact mechanisms behind the success of ECT therapy are not known, it is believed that this electrical current alters the electrochemical processes of the brain, consequently relieving depression. Headaches, muscle soreness, nausea, and confusion are possible side effects immediately following an ECT procedure. Temporary memory loss has also been reported in ECT patients. In bipolar patients, ECT is often used in conjunction with drug therapy.

Adjunct Therapies

Other drugs that may be use as adjunct therapies (i.e., in addition to regular treatment) to treat manic episodes include the following:

  • Calcium channel blockers: Nimodipine (Nimotop, Admon) and verapamil (Calan, Covera, Isoptin), typically used to treat angina and hypotension, have been found effective in a few small studies, for treating rapid cyclers. Calcium channel blockers stop the excess calcium build up in cells that is thought to be a cause of bipolar disorder. They usually are used in conjunction with other drug therapies such as carbamazepine or lithium.
  • Long-acting benzodiazepines: Lorazepam (Ativan), clonazepam (Klonapin), and alprazolam (Xanax) are used for rapid treatment of manic symptoms to calm and sedate patients until mania or hypomania have waned and mood stabilizing agents can take effect. Sedation is a common effect, and clumsiness, lightheadedness, and slurred speech are other possible side effects of benzodiazepines.
  • Neuroleptics: Chlorpromazine (Thorazine) and haloperidol (Haldol) are also used to control mania while a mood stabilizer such as lithium or valproate takes effect. Because the side effects of these drugs can be severe (difficulty in speaking or swallowing, paralysis of the eyes, loss of balance control, muscle spasms, severe restlessness, stiffness of arms and legs, tremors in fingers and hands, twisting movements of body, and weakness of arms and legs), benzodiazepines are generally preferred over neuroleptics.

Because bipolar disorder is thought to be biological in nature, therapy and/or counseling is recommended as a companion to, but not a substitute for, pharmaceutical treatment of the disease. Psychotherapy, such as cognitive-behavioral therapy, can be a useful tool in helping patients and their families adjust to the disorder, in encouraging compliance to a medication regimen, and in reducing the risk of suicide. A 2003 report revealed that people on medication for bipolar disorder had better results if they also participated in family-focused therapy.

Alternative Treatment

General recommendations include maintaining a calm environment, avoiding overstimulation, getting plenty of rest, regular exercise, and proper diet. Biofeedback may be effective in helping some children and adolescents control symptoms such as irritability, poor self control, racing thoughts, and sleep problems. A diet low in vanadium (a mineral found in meats and other foods) and high in vitamin C may be helpful in reducing depression.

Repeated transcranial magnetic stimulation (rTMS) is a new and still experimental treatment for the depressive phase of bipolar disorder. In rTMS, a large magnet is placed on the patient's head and magnetic fields of different frequency are generated to stimulate the left front cortex of the brain. Unlike ECT, rTMS requires no anesthesia and does not induce seizures.

Prognosis

While most children show some positive response to treatment, response varies widely, from full recovery to a complete lack of response to all drug and/or ECT therapy. Drug therapies frequently need adjustment to achieve the maximum benefit for the patient. Bipolar disorder is a chronic recurrent illness in over 90 percent of those afflicted, and one that requires lifelong observation and treatment after diagnosis. Patients with untreated or inadequately treated bipolar disorder have a suicide rate of 15 to 25 percent and a nine-year decrease in life expectancy. With proper treatment, the life expectancy of the bipolar patient will increase by nearly seven years and work productivity increases by 10 years.

According to the American Psychiatric Association, bipolar children and adolescents experiencing a manic episode have a one-year recovery rate of 37.1 percent and a relapse rate of 38.3 percent. Discontinuing lithium treatment too early may increase the risk of relapse in adolescents with bipolar disorder. In one 1990 study, 92 percent of adolescents hospitalized for mania who stopped taking the drug experienced a relapse of symptoms within 18 months of discharge, compared to 37 percent of those who stayed on lithium therapy.

Children and teens with bipolar disorder are at a greater risk for substance abuse than their non-bipolar peers, and substance abuse can worsen or complicate bipolar treatment. In a 1999 two-year follow-up study of adolescents hospitalized for manic episodes, patients who had ongoing drug or alcohol abuse problems had more manic episodes and poorer functioning than those patients who were not substance abusers. In addition, some studies have indicated that children who develop bipolar disorder in adolescence are more likely to develop a substance abuse problem than those who have early-onset of bipolar disorder in childhood.

Prevention

The ongoing medical management of bipolar disorder is critical for preventing relapse, or recurrence, of manic episodes. Even in carefully controlled treatment programs, bipolar patients may experience recurring episodes of the disorder. Education in the form of psychotherapy or self-help groups is crucial for training bipolar patients and their caregivers to recognize signs of mania and depression and to take an active part in their treatment program.

Parental Concerns

Children with bipolar disorder may require special accommodations in the classroom. Section 504 of the Rehabilitation Act of 1973 enables parents to develop both a Section 504 plan (which describes a child's medical needs) and an individualized education plan (IEP), which describes what special accommodations a child requires to address those needs. The IEP may cover issues such as allowing extra time on tests, modifying assignments, and providing home tutoring or a classroom aide when necessary.

Children who are diagnosed with bipolar disorder should be reassured that the condition is due to factors beyond their control (i.e., genetics, neurochemical imbalance) rather than any fault of their own. For those children and teens who feel stigmatized or self-conscious about their diagnosis, arranging psychotherapy sessions outside school hours may lessen their burden. Any child on prescription medication for bipolar disorder should be carefully monitored for any sign of side effects, and these should be reported to their physician when they do occur. A dosage adjustment or medication change may be warranted if side effects are disruptive or potentially dangerous.

See also Depressive disorders; Minnesota Multiphasic Personality Inventory.

Resources

Books

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Press Inc., 2000.

Papolos, Demitri, and Janice Papolos. The Bipolar Child, 2nd ed. New York: Broadway Books, 2002.

Periodicals

American Psychiatric Association. "Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision)." American Journal of Psychiatry149, no.4.(April2002):1–50.

"Education and Your Bipolar Child." Brown University Child and Adolescent Behavior Letter 20, no. 7 (July 2004): 9.

"Lithium and Risk of Suicide." The Lancet (September 20, 2003): 969.

"Schizophrenia and Bipolar Disorder Could Have Similar Genetic Causes." Genomics & Genetics Weekly (September 26, 2003): 85.

Sherman, Carl. "Bipolar's Clinical, Financial Impact Widely Missed. (Prevalence May Be Greater than Expected)." Clinical Psychiatry News (August 2002): 6.

Organizations

American Psychiatric Association. 1000 Wilson Blvd., Suite 1825, Arlington, VA 22209. Web site: www.psych.org.

American Psychological Association (APA). 750 First St. NE, Washington, DC 20002–4242. Web site: www.apa.org.

Child and Adolescent Bipolar Foundation (CABF). 1187 Wilmette Ave., PMB #331, Wilmette, IL 60091. Web site: www.bpkids.org.

Depression and Bipolar Support Alliance (DBSA). 730 N. Franklin St., Suite 501, Chicago, IL 60610. Web site: www.dbsalliance.org.

National Alliance for the Mentally Ill (NAMI). Colonial Place Three, 2107 Wilson Blvd., Ste. 300, Arlington, VA 22201–3042. Web site: www.nami.org.

National Institute of Mental Health (NIMH). Office of Communications, 6001 Executive Boulevard, Room 8184, MSC 9663, Bethesda, MD 20892–9663. Web site: www.nimh.nih.gov.

Web Sites

U.S. Food and Drug Administration. "Antidepressant Use in Children, Adolescents, and Adults." Available online at www.fda.gov/cder/drug/antidepressants/default.htm (accessed November 9, 2004).

[Article by: Paula Ford-Martin Teresa Odle]



 
Britannica Concise Encyclopedia: bipolar disorder
Top

Mental illness characterized by the alternation of manic and depressive states. Depression is the more common symptom, and many patients experience only a brief period of overoptimism and mild euphoria during the manic phase. The condition, which seems to be inheritable, probably arises from malregulation of the amines norepinephrine, dopamine, and 5-hydroxytryptamine. It is most commonly treated with lithium carbonate.

For more information on bipolar disorder, visit Britannica.com.

 
Columbia Encyclopedia: bipolar disorder
Top
bipolar disorder, formerly manic-depressive disorder or manic-depression, severe mental disorder involving manic episodes that are usually accompanied by episodes of depression. The term “manic-depression” was introduced by the German psychiatrist Emil Kraepelin in 1896. The manic phase of the disorder is characterized by an abnormally elevated or irritable mood, grandiosity, sleeplessness, extravagance, and a tendency toward irrational judgment. During the depressed phase, the person tends to appear lethargic and withdrawn, shows a lack of concentration, and expresses feelings of worthlessness, self-blame, and guilt. This dual character of the disorder has given it the name bipolar disorder, in contrast to the unipolar depression symptomatic of the majority of mood disorders. The symptoms range in intensity and pattern and may not be recognized at first. Individuals suffering from bipolar disorder may have long periods in their lives without episodes of mania or depression, but manic-depressives have the highest suicide rate of any group with a psychological disorder.

Incidence

Estimates suggest that about 2 million Americans suffer from bipolar disorders. Symptoms usually appear in adolescence or early adulthood and continue throughout life. The disorder occurs in males and females equally and is found more frequently in close relatives of people already known to have it.. It has had notable incidence among creative individuals, affecting such artists as Hector Berlioz, Gustav Mahler, Ernest Hemingway, and Virginia Woolf.

Treatment

Therapy includes lithium (to control mania and stabilize mood swings), anticonvulsant drugs such as valproate and carbamazepine, and antidepressants. Electroconvulsive therapy has been useful in cases where other treatments have had little success. Psychotherapy can provide support to the patient and the family.

Bibliography

See F. K. Goodwin and K. R. Jamison, Manic-Depressive Illness (1990); publications of the National Institute of Mental Health.


 
Health Dictionary: bipolar disorder
Top

Also known as manic-depressive illness. This psychiatric disorder is marked by periods of euphoric (manic) highs often followed by periods of depression.

 
Wikipedia: Bipolar disorder
Top
Bipolar disorder
Classification and external resources
ICD-10 F31.
ICD-9 296.80
OMIM 125480 309200
DiseasesDB 7812
MedlinePlus 001528
eMedicine med/229 
MeSH D001714

Bipolar disorder, also known as manic depression, manic depressive disorder or bipolar affective disorder, is a psychiatric diagnosis that describes a category of mood disorders defined by the presence of one or more episodes of abnormally elevated mood clinically referred to as mania or, if milder, hypomania. Individuals who experience manic episodes also commonly experience depressive episodes or symptoms, or mixed episodes in which features of both mania and depression are present at the same time. These episodes are usually separated by periods of "normal" mood, but in some individuals, depression and mania may rapidly alternate, known as rapid cycling. Extreme manic episodes can sometimes lead to psychotic symptoms such as delusions and hallucinations. The disorder has been subdivided into bipolar I, bipolar II, cyclothymia, and other types, based on the nature and severity of mood episodes experienced; the range is often described as the bipolar spectrum.

Data from the United States on lifetime prevalence varies, but indicates a rate of around 1 percent for Bipolar I, 0.5 to 1 percent for Bipolar II or cyclothymia, and between 2 and 5 percent for subthreshold cases meeting some, but not all, criteria. The onset of full symptoms generally occurs in late adolescence or young adulthood. Diagnosis is based on the person's self-reported experiences, as well as observed behavior. Episodes of abnormality are associated with distress and disruption, and an elevated risk of suicide, especially during depressive episodes. In some cases it can be a devastating long-lasting disorder; in others it has also been associated with creativity, goal striving and positive achievements.[1]

Genetic factors contribute substantially to the likelihood of developing bipolar disorder, and environmental factors are also implicated. Bipolar disorder is often treated with mood stabilizer medications, and sometimes other psychiatric drugs. Psychotherapy also has a role, often when there has been some recovery of stability. In serious cases in which there is a risk of harm to oneself or others involuntary commitment may be used; these cases generally involve severe manic episodes with dangerous behavior or depressive episodes with suicidal ideation. There are widespread problems with social stigma, stereotypes and prejudice against individuals with a diagnosis of bipolar disorder.[2] People with bipolar disorder exhibiting psychotic symptoms can sometimes be misdiagnosed as suffering from schizophrenia, another serious mental illness.[3]

The current term "bipolar disorder" is of fairly recent origin and refers to the cycling between high and low episodes (poles). A relationship between mania and melancholia had long been observed, although the basis of the current conceptualisation can be traced back to French psychiatrists in the 1850s. The term "manic-depressive illness" or psychosis was coined by German psychiatrist Emil Kraepelin in the late nineteenth century, originally referring to all kinds of mood disorder. German psychiatrist Karl Leonhard split the classification again in 1957, employing the terms unipolar disorder (major depressive disorder) and bipolar disorder.

Contents

Signs and symptoms

Bipolar disorder is a condition in which people experience abnormally elevated (manic or hypomanic) and abnormally depressed states for a period of time in a way that interferes with functioning. Bipolar disorder has been estimated to afflict more than 5 million Americans—about 1 out of every 45 adults.[4] It is equally prevalent in men and women, and is found across all cultures and ethnic groups.[5] Not everyone's symptoms are the same, and there is no blood test to confirm the disorder. Scientists believe that bipolar disorder may be caused by chemical imbalances in the brain. Bipolar disorder can appear to be unipolar depression. Diagnosing bipolar disorder is difficult, even for mental health professionals. What distinguishes bipolar disorder from unipolar depression is that the affected person jumps between states of mania and depression. Often bipolar is inconsistent among patients because some people feel depressed more often than not and experience little mania whereas others may predominantly experience manic symptom.

Major depressive episode

Signs and symptoms of the depressive phase of bipolar disorder include persistent feelings of sadness, anxiety, guilt, anger, isolation, or hopelessness; disturbances in sleep and appetite; fatigue and loss of interest in usually enjoyable activities; problems concentrating; loneliness, self-loathing, apathy or indifference; depersonalization; loss of interest in sexual activity; shyness or social anxiety; irritability, chronic pain (with or without a known cause); lack of motivation; and morbid suicidal ideation.[6] In severe cases, the individual may become psychotic, a condition also known as severe bipolar depression with psychotic features.

Manic episode

Mania is generally characterized by a distinct period of an elevated, expansive, or irritable mood state. People commonly experience an increase in energy and a decreased need for sleep. A person's speech may be pressured, with thoughts experienced as racing. Attention span is low and a person in a manic state may be easily distracted. Judgment may become impaired; sufferers may go on spending sprees or engage in behavior that is quite abnormal for them. They may indulge in substance abuse, particularly alcohol or other depressants, cocaine or other stimulants, or sleeping pills. Their behavior may become aggressive, intolerant or intrusive. People may feel out of control or unstoppable. People may feel they have been "chosen", are "on a special mission", or other grandiose or delusional ideas. Sexual drive may increase. At more extreme phases of bipolar I, a person in a manic state can begin to experience psychosis, or a break with reality, where thinking is affected along with mood.[7] Many people in a manic state experience severe anxiety and are very irritable (to the point of rage), while others are euphoric and grandiose.

In order to be diagnosed with mania according to the Diagnostic and Statistical Manual of Mental Disorders (commonly referred to as the DSM) a person must experience this state of elevated or irritable mood, as well as other symptoms, for at least one week, less if hospitalization is required. According to the National Institute of Mental Health, "A manic episode is diagnosed if elevated mood occurs with three or more of the other symptoms most of the day, nearly every day, for 1 week or longer. If the mood is irritable, four additional symptoms must be present."[8]

Hypomanic episode

Hypomania is generally a mild to moderate level of mania, characterized by optimism, pressure of speech and activity, and decreased need for sleep. Some people have increased creativity while others demonstrate poor judgment and irritability. These persons generally have increased energy and tend to become more active than usual. They do not, however, have delusions or hallucinations. Hypomania can be difficult to diagnose because it may masquerade as mere happiness, though it carries the same risks as mania.

Hypomania may feel good to the person who experiences it. Thus, even when family and friends learn to recognize the mood swings, the individual often will deny that anything is wrong.[9]

Mixed affective episode

In the context of bipolar disorder, a mixed state is a condition during which symptoms of mania and clinical depression occur simultaneously (for example, agitation, anxiety, aggressiveness or belligerence, confusion, fatigue, impulsiveness, insomnia, irritability, morbid and/or suicidal ideation, panic, paranoia, persecutory delusions, pressured speech, racing thoughts, restlessness, and rage).[10]

Diagnosis

Manic and depressive episodes, hallmarks of Bipolar Disorder, have been compared to a roller coaster ride.[11]

Diagnosis is based on the self-reported experiences of an individual as well as abnormalities in behavior reported by family members, friends or co-workers, followed by secondary signs observed by a psychiatrist, nurse, social worker, clinical psychologist or other clinician in a clinical assessment. There are lists of criteria for someone to be so diagnosed. These depend on both the presence and duration of certain signs and symptoms. Assessment is usually done on an outpatient basis; admission to an inpatient facility is considered if there is a risk to oneself or others. The most widely used criteria for diagnosing bipolar disorder are from the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, the current version being DSM-IV-TR, and the World Health Organization's International Statistical Classification of Diseases and Related Health Problems, currently the ICD-10. The latter criteria are typically used in Europe and other regions while the DSM criteria are used in the USA and other regions, as well as prevailing in research studies.

An initial assessment may include a physical exam by a physician. Although there are no biological tests which confirm bipolar disorder, tests may be carried out to exclude medical illnesses such as hypo- or hyperthyroidism, metabolic disturbance, a systemic infection or chronic disease, and syphilis or HIV infection. An EEG may be used to exclude epilepsy, and a CT scan of the head to exclude brain lesions. Investigations are not generally repeated for relapse unless there is a specific medical indication.

There are several other mental disorders which may involve similar symptoms to bipolar disorder. These include schizophrenia,[12] schizoaffective disorder, drug intoxication, brief drug-induced psychosis, schizophreniform disorder and borderline personality disorder. Both borderline personality and bipolar disorder can involve what are referred to as "mood swings". In bipolar disorder, the term refers to the cyclic episodes of elevated and depressed mood which generally last weeks or months. The term in borderline personality refers to the marked lability and reactivity of mood, known as emotional dysregulation, due to response to external psychosocial and intrapsychic stressors; these may arise or subside suddenly and dramatically and last for seconds, minutes, hours or days. A bipolar depression is generally more pervasive with sleep, appetite disturbance and nonreactive mood, whereas the mood in dysthymia of borderline personality remains markedly reactive and sleep disturbance not acute.[13] Some hold that borderline personality disorder represents a subthreshold form of mood disorder,[14][15] while others maintain the distinctness, though noting they often coexist.[16][17]

Clinical Scales

The Bipolar Spectrum Diagnostic Scale (BSDS)[18] was developed by Ronald Pies, MD and was later refined and tested by S. Nassir Ghaemi, MD, MPH and colleagues. The BSDS arose from Pies's experience as a psychopharmacology consultant, where he was frequently called on to manage cases of "treatment-resistant depression." There are 19 question items and 2 sections on the English version of the BSDS. The scale was validated in its original version and demonstrated a high sensitivity.[19]

Criteria and subtypes

There is no clear consensus as to how many types of bipolar disorder exist.[20] In DSM-IV-TR and ICD-10, bipolar disorder is conceptualized as a spectrum of disorders occurring on a continuum. The DSM-IV-TR lists four types of mood disorders which fit into the bipolar categories: Bipolar I, Bipolar II, Cyclothymia, and Bipolar Disorder NOS (Not Otherwise Specified).

Bipolar I

In Bipolar I disorder, an individual has experienced one or more manic episodes with or without major depressive episodes. For a diagnosis of Bipolar I disorder according to the DSM-IV-TR, one or more manic or mixed episodes are required. A depressive episode is not required for the diagnosis of Bipolar I disorder but it frequently occurs.

Bipolar II

Bipolar II disorder is characterized by hypomanic episodes rather than actual manic episodes, as well as at least one major depressive episode. Patients with a Bipolar II diagnosis under the DSM IV criteria cannot, by definition, ever have had a manic episode prior to their diagnosis. However, a Bipolar II diagnosis is not a guarantee that they will not eventually suffer from such an episode in the future.[citation needed]

Hypomanic episodes do not go to the full extremes of mania (i.e. do not usually cause severe social or occupational impairment, and without psychosis), and this can make Bipolar II more difficult to diagnose, since the hypomanic episodes may simply appear as a period of successful high productivity and is reported less frequently than a distressing, crippling depression. For both Bipolar I and II, there are a number of specifiers that indicate the presentation and course of the disorder, including "chronic", "rapid cycling", "catatonic" and "melancholic".

Cyclothymia

Cyclothymia involves a presence or history of hypomanic episodes with periods of depression that do not meet criteria for major depressive episodes. A diagnosis of Cyclothymic Disorder requires the presence of numerous hypomanic episodes, intermingled with depressive episodes that do not meet full criteria for major depressive episodes. The main idea here is that there is a low-grade cycling of mood which appears to the observer as a personality trait, but interferes with functioning.

Bipolar NOS

Bipolar Disorder NOS, sometimes called "sub-threshold" Bipolar Disorder, is a "catch-all" diagnosis that is used to indicate bipolar illness that does not fit into any of the formal DSM-IV bipolar diagnostic categories (Bipolar I, Bipolar II, or cyclothymia). If an individual seems to be suffering from bipolar spectrum symptoms (e.g. some manic and depressive symptoms) but does not meet the criteria for one of the subtypes mentioned above, he or she receives a diagnosis of Bipolar Disorder NOS (Not Otherwise Specified). Despite not fully meeting one of the formal diagnostic categories, Bipolar NOS can still significantly impair and adversely affect the quality of life of the patient.

Rapid cycling

Most people who meet criteria for bipolar disorder experience a number of episodes, on average 0.4 to 0.7 per year, lasting three to six months.[21][22]

Rapid cycling, however, is a course specifier that may be applied to any of the above subtypes. It is defined as having four or more episodes per year and is found in a significant fraction of individuals with bipolar disorder. The definition of rapid cycling most frequently cited in the literature (including the DSM) is that of Dunner and Fieve: at least four major depressive, manic, hypomanic or mixed episodes are required to have occurred during a 12-month period.[23] There are references that describe very rapid (ultra-rapid) or extremely rapid[24] (ultra-ultra or ultradian) cycling. One definition of ultra-ultra rapid cycling is defining distinct shifts in mood within a 24–48-hour period.

Challenges

The experiences and behaviors involved in bipolar disorder are often not understood by individuals or recognized by mental health professionals, so diagnosis may sometimes be delayed for 10 years or more.[25] That treatment lag is apparently not decreasing, even though there is now increased public awareness of this mental health condition in popular magazines and health websites. Despite this increased focus, individuals are still commonly misdiagnosed.[26] An individual may appear simply depressed when they are seen by a health professional. This can result in misdiagnosis of Major Depressive Disorder and harmful treatments. Recent screening tools such as the Hypomanic Check List Questionnaire (HCL-32)[27] have been developed to assist the quite often difficult detection of Bipolar II disorders.

It has been noted that the bipolar disorder diagnosis is officially characterised in historical terms such that, technically, anyone with a history of (hypo)mania and depression has bipolar disorder whatever their current or future functioning and vulnerability. This has been described as "an ethical and methodological issue", as it means no one can be considered as being recovered from bipolar disorder according to the official criteria. This is considered especially problematic given that brief hypomanic episodes are widespread among people generally and not necessarily associated with dysfunction.[28]

Flux is the fundamental nature of bipolar disorder.[29] Individuals with the illness have continual changes in energy, mood, thought, sleep, and activity. The diagnostic subtypes of bipolar disorder are thus static descriptions—snapshots, perhaps—of an illness in continual flux, with a great diversity of symptoms and varying degrees of severity. Individuals may stay in one subtype, or change into another, over the course of their illness.[30] The DSM V, to be published in 2012, will likely include further and more accurate sub-typing (Akiskal and Ghaemi, 2006).

The diagnosis of bipolar disorder can be complicated by coexisting psychiatric conditions such as obsessive-compulsive disorder, social phobia, panic disorder, or attention-deficit/hyperactivity disorder. Substance abuse may predate the appearance of bipolar symptoms, further complicating the diagnosis. A careful longitudinal analysis of symptoms and episodes, enriched if possible by discussions with friends and family members, is crucial to establishing a valid treatment plan where these comorbidities exist. [31]

The diagnosis of bipolar disorder in children is particularly challenging, and controversial. Some who show some bipolar symptoms tend to have a rapid-cycling or mixed-cycling pattern that may not meet DSM-IV criteria.[32] In addition, it can be difficult to distinguish between age-appropriate restlessness, the fidgeting of children with ADHD, and the purposeful busy activity of mania.[33] Further complicating the diagnosis, is that abused or traumatized children can seem to have bipolar disorder when they are actually reacting to horrors in their lives.[34]

In the elderly, recognition and treatment of bipolar disorder may be complicated by the presence of dementia or the side effects of medications being taken for other conditions.[35] As yet there is very little evidence-based research to guide management of bipolar in the elderly as opposed to adults in general.

Associated features

Associated features are clinical phenomena that often accompany the disorder, but are not part of the diagnostic criteria for the disorder.

Cognitive functioning

Mild cognitive impairment in bipolar disorder is a controversial issue

So called cognitive deficits in bipolar disorder are relatively mild and can only be detected by comparing performance in neuropsychological tests between groups of patients compared to those without the diagnosis.[citation needed] It should be stressed that although on average those with bipolar disorder perform worse in some tasks compared to controls, some patients will actually perform better than controls because of the large variation in test scores.

It has been concluded from recent reviews that most individuals who were diagnosed with bipolar disorder but who are euthymic (have not experienced major depression or (hypo)mania for some time) do not show neuropsychological deficits on most tests.[28] Meta-analyses have indicated, by averaging the variable findings of many studies, impaired performance on some measures of sustained attention, executive function and memory, in terms of group averages. The effects of subthreshold mood states and psychiatric medications appear to account for some of the association.[36][37]

It is not known whether specific cognitive deficits are disorder-specific features of bipolar disorder.[citation needed]

Creativity and accomplishment

Some historians[who?] believe Vincent van Gogh suffered from Bipolar Disorder

While the disorder affects people differently, individuals with bipolar disorder during the manic phase tend to be much more outgoing and daring than individuals without bipolar disorder. In common with other major affective disorders such as unipolar depression, bipolar disorder is found in a large number of people involved in the arts.[38][39][40] It is an ongoing question as to whether many creative geniuses had bipolar disorder. Some studies have found a significant correlation between creativity and bipolar disorder. Though studies consistently show a positive correlation between the two, it is unclear in which direction the cause lies, or whether both conditions are caused by a third unknown factor. Temperament has been hypothesized to be one such factor.[41][42][43]

A series of authors have described mania or hypomania as related to higher accomplishment, elevated achievement motivation and ambitious goal setting. One study indicated that greater-than-average striving for goals, and sometimes obtaining them, corresponded with mania.[44]

Epidemiology

The lifetime prevalence of bipolar disorder type I, which includes at least a lifetime manic episode, has generally been estimated at 2%.[45] A reanalysis of data from the National Epidemiological Catchment Area survey in the United States, however, suggested that 0.8 percent experience a manic episode at least once (the diagnostic threshold for bipolar I) and 0.5 a hypomanic episode (the diagnostic threshold for bipolar II or cyclothymia). Including sub-threshold diagnostic criteria, such as one or two symptoms over a short time-period, an additional 5.1 percent of the population, adding up to a total of 6.4 percent, were classed as having a bipolar spectrum disorder.[46] A more recent analysis of data from a second US National Comorbidity Survey found that 1% met lifetime prevalence criteria for bipolar 1, 1.1% for bipolar II, and 2.4% for subthreshold symptoms.[47] There are conceptual and methodological limitations and variations in the findings. Prevalence studies of bipolar disorder are typically carried out by lay interviewers who follow fully structured/fixed interview schemes; responses to single items from such interviews may suffer limited validity. In addition, diagnosis and prevalence rates are dependent on whether a categorical or spectrum approach is used. Concerns have arisen about the potential for both underdiagnosis and overdiagnosis.[48]

Late adolescence and early adulthood are peak years for the onset of bipolar disorder.[49][50] These are critical periods in a young adult's social and vocational development, and they can be severely disrupted.

Major depressive disorder and bipolar disorder are currently classified as separate disorders. Some researchers increasingly view them as part of an overlapping spectrum that also includes anxiety and psychosis. According to Hagop Akiskal, M.D., at the one end of the spectrum is bipolar type schizoaffective disorder, and at the other end is recurrent unipolar depression, with the anxiety disorders present across the spectrum. Also included in this view is premenstrual dysphoric disorder, postpartum depression, and postpartum psychosis. This view helps to explain why many people who have the illness do not have first-degree relatives with clear-cut "bipolar disorder", but who have family members with a history of these other disorders.

Children

In professional classifications such as the American Psychiatric Association's Diagnostic and Statistical Manual (DSM) [51] or the World Health Organization's International Classification of Diseases (ICD)[52] bipolar disorder is classified with adult onset disorders. However, as far back as the 1920s, Kraepelin [53] showed in a retrospective study of 900 manic-depressive adults that 0.4% had onset of symptoms before the age of ten. In a cohort of bipolar disordered adults, Loranger and Levine [54] retrospectively evaluated 200 adult bipolar patients and found that 0.5% had onset between the ages of five and nine. In a study of 898 adults with bipolar disorder, Goodwin and Jamison [55] found that 0.3% had onset before age 10. This literature supported the existence of childhood onset mania, but also indicated that it may be rare.

This idea was supported by a review of 28 papers by Anthony and Scott[56], which suggested that childhood bipolar disorder was uncommon. In these papers, only three of 60 cases (5%) of purported childhood bipolar disorder met their criteria for bipolar disorder. However, Anthony and Scott's criteria differed from those currently in use, so the applicability of this work to current views of bipolar disorder is uncertain.

Population and community studies using DSM criteria show that about 1% of youth may have bipolar disorder [57][58]. Studies in clinics using these criteria show that up to 20% of youth referred to psychiatric clinics have bipolar disorder [59][60][61]. Many of these children required hospitalization due to the severity of their disorder [62][63].

Because of these dignostic uncertainties, the validity of an early-onset form of bipolar disorder had been debated in the late 20th century. However, since that time, systematic reviews of diagnostic, genetic, neurobiological, treatment and longitudinal research studies [64][65][66][67] have concluded that this disorder can be validly diagnosed in children and adolescents. This consensus of the scientific community is also seen in the appearance of practice parameters for the disorder from the American Academy of Child and Adolescent Psychiatry[68] Findings indicate that the number of American [children] and [adolescents] treated for bipolar disorder increased 40-fold from 1994 to 2003, and continues to increase. The data suggest that doctors had been more aggressively applying the diagnosis to children, rather than that the incidence of the disorder has increased. The study calculated the number of psychiatric visits increased from 20,000 in 1994 to 800,000 in 2003, or 1% of the [population] under age 20.[69]

The reasons for this increase in diagnosis are unclear. On the one hand, the recent consensus from the scientific community (see above) will have educated clinicians about the nature of the disorder and the methods for diagnosis and treatment in children. That, in turn, should increase the rate of diagnosis. On the other hand, assumptions regarding behavior, particularly in regard to the differential diagnosis of bipolar disorder, ADHD, and conduct disorder in children and adolescents, may also play a role.

Another factor is that the "consensus" regarding the diagnosis in the pediatric age group seems to apply only to the USA. The British National Institute on Health and Clinical Excellence (NICE) guidelines on bipolar disorder in 2006 [70] specifically described the broadened criteria used in the USA to diagnose bipolar disorder in children as suitable "only for research" and "were not convinced that evidence currently exists to support the everyday clinical use of (pediatric bipolar phenotype) diagnoses" which increase the "risk that medicines may be used to inappropriately treat a bipolar diathesis that does not exist."(p526). A 2002 German survey [71]of 251 child and adolescent psychiatrists (average 15 years clinical experience) found only 8% had ever diagnosed a pre-pubertal case of bipolar disorder in their careers. A similar survey of 199 child & adolescent psychiatrists (av 15 years clinical experience) in Australia and New Zealand [72]also found much lower rates of diagnosis than in the USA and a consensus that bipolar disorder was overdiagnosed in children and youth in the USA. Concerns about overdiagnosis in the USA have also been expressed by American child & adolescent psychiatrists [73][74][75][76] and a series of essays in the book "Bipolar children: Cutting-edge controversy, insights and research" [77]highlight several controversies and suggest the science still lacks consensus with regard to bipolar disorder diagnosis in the pediatric age group.

Although accurately diagnosing all disorders in children is important, for bipolar disorder, it is critical. On the one hand, the antipsychotic drugs sometimes prescribed for the treatment of bipolar disorder may increase risk to health including heart problems, diabetes, liver failure, and death.[78] On the other hand, bipolar disorder is a very disabling disorder which leads to many impairments in children, including cognitive impairment[79][80][81], psychiatric hospitalization[82][83][84][85][86], psychosis [87][88][89][90] and suicide[91]. Thus, physicians, parents and patients need to weight the potential risks and benefits when treating this disorder[92].

Older age

There is a relative lack of knowledge about bipolar disorder in late life. There is evidence that it becomes less prevalent with age but nevertheless accounts for a similar percentage of psychiatric admissions; that older bipolar patients had first experienced symptoms at a later age; that later onset of mania is associated with more neurologic impairment; that substance abuse is considerably less common in older groups; and that there is probably a greater degree of variation in presentation and course, for instance individuals may develop new-onset mania associated with vascular changes, or become manic only after recurrent depressive episodes, or may have been diagnosed with bipolar disorder at an early age and still meet criteria. There is also some weak evidence that mania is less intense and there is a higher prevalence of mixed episodes, although there may be a reduced response to treatment. Overall there are likely more similarities than differences from younger adults.[93]

Causes

The causes of bipolar disorder likely vary between individuals. Twin studies have been limited by relatively small sample sizes but have indicated a substantial genetic contribution, as well as environmental influence. For Bipolar I, the (probandwise) concordance rates in modern studies have been consistently put at around 40% in monozygotic twins (same genes), compared to 0 to 10% in dizygotic twins.[94] A combination of bipolar I, II and cyclothymia produced concordance rates of 42% vs 11%, with a relatively lower ratio for bipolar II that likely reflects heterogeneity. The overall heritability of the bipolar spectrum has been put at 0.71.[95] There is overlap with unipolar depression and if this is also counted in the co-twin the concordance with bipolar disorder rises to 67% (Mz) and 19% (Dz).[96] The relatively low concordance between dizygotic twins brought up together suggests that shared family environmental effects are limited, although the ability to detect them has been limited by small sample sizes.[95]

Genetic

Genetic influences are thought to be important in bipolar disorder

Genetic studies have suggested many chromosomal regions and candidate genes appearing to relate to the development of bipolar disorder, but the results are not consistent and often not replicated.[97] Although the first genetic linkage finding for mania was in 1969,[98] the linkage studies have been inconsistent.[99] (Genetic linkage studies may be followed by fine mapping searching for the phenomenon of linkage disequilibrium with a single gene, then DNA sequencing; using this approach causative DNA base pair changes have been reported for the genes P2RX7[100] and TPH1[citation needed]). Recent meta-analyses of linkage studies detected either no significant genome-wide findings or, using a different methodology, only two genome-wide significant peaks, on chromosome 6q and on 8q21. Genome-wide association studies have also not brought a consistent focus — each has identified new loci, while none of the previously identified loci were replicated.[99] Findings did include a single nucleotide polymorphism in DGKH;[101] a locus in a gene-rich region of high linkage disequilibrium (LD) on chromosome 16p12;[102] and a single nucleotide polymorphism in MYO5B.[103] A comparison of these studies, combined with a new study, suggested an association with ANK3 and CACNA1C, thought to be related to calcium and sodium voltage-gated ion channels.[104] Diverse findings point strongly to heterogeneity, with different genes being implicated in different families.[105] Numerous specific studies find various specific links.[106][107][108][109][110] Advanced parental age has been linked to a somewhat increased chance of bipolar disorder in offspring, consistent with a hypothesis of increased new genetic mutations.[111] A review seeking to identify the more consistent findings suggested several genes related to serotonin (SLC6A4 and TPH2), dopamine (DRD4 and SLC6A3), glutamate (DAOA and DTNBP1), and cell growth and/or maintenance pathways (NRG1, DISC1 and BDNF), although noting a high risk of false positives in the published literature. It was also suggested that individual genes are likely to have only a small effect and to be involved in some aspect related to the disorder (and a broad range of "normal" human behavior) rather than the disorder per se.[112]

Childhood precursors

Some limited long-term studies indicate that children who later receive a diagnosis of bipolar disorder may show subtle early traits such as subthreshold cyclical mood abnormalities, full major depressive episodes, and possibly ADHD with mood fluctuation. There may be hypersensitivity and irritability. There is some disagreement whether the experiences are necessarily fluctuating or may be chronic.[113] A history of stimulant use in childhood is found in high numbers of bipolar patients and has been found to cause an earlier onset of bipolar disorder, worse clinical course, independent of attention deficit hyperactivity disorder.[114][115][116]

Life events and experiences

Evidence suggests that environmental factors play a significant role in the development and course of bipolar disorder, and that individual psychosocial variables may interact with genetic dispositions.[112] There is fairly consistent evidence from prospective studies that recent life events and interpersonal relationships contribute to the likelihood of onsets and recurrences of bipolar mood episodes, as they do for onsets and recurrences of unipolar depression.[117] There have been repeated findings that between a third and a half of adults diagnosed with bipolar disorder report traumatic/abusive experiences in childhood, which is associated on average with earlier onset, a worse course, and more co-occurring disorders such as PTSD.[118] The total number of reported stressful events in childhood is higher in those with an adult diagnosis of bipolar spectrum disorder compared to those without, particularly events stemming from a harsh environment rather than from the child's own behavior.[119] Early experiences of adversity and conflict are likely to make subsequent developmental challenges in adolescence more difficult, and are likely a potentiating factor in those at risk of developing bipolar disorder.[113]

Neural processes

Hyperintensities (bright areas on MRI scans above) are 2.5 times more likely to occur in bipolar disorder

Researchers hypothesize that abnormalities in the structure and/or function of certain brain circuits could underlie bipolar and other mood disorders. Some studies have found anatomical differences in areas such as the amygdala,[120] prefrontal cortex[121] and hippocampus. However, despite 25 years of research involving more than 7000 MRI scans, studies continue to report conflicting findings and there remains considerable debate over the neuroscientific findings. Two fairly consistent abnormalities found in a meta-analysis of 98 MRI or CT neuroimaging studies were that groups with bipolar disorder had lateral ventricles which were on average 17% larger than control groups, and were 2.5 times more likely to have deep white matter hyperintensities. Given the size of the meta-analysis, it was concluded that the relatively small number of significant findings was perhaps surprising, and that there may be genuinely limited structural change in bipolar disorder, or perhaps heterogeneity has obscured other differences. In addition, it was noted that averaged associations found at the level of multiple studies may not exist for an individual.[122]

The "kindling" theory asserts that people who are genetically predisposed toward bipolar disorder can experience a series of stressful events,[123] each of which lowers the threshold at which mood changes occur. Eventually, a mood episode can start (and become recurrent) by itself. There is evidence of hypothalamic-pituitary-adrenal axis (HPA axis) abnormalities in bipolar disorder due to stress.[124]

Recent research in Japan hypothesizes that dysfunctional mitochondria in the brain may play a role [125]

Other recent research in [WHERE?] implicates issues with a sodium ATPase pump,[126] causing cyclical periods of poor neuron firing (depression) and hyper sensitive neuron firing (mania). This may only apply for type one, but type two apparently results from a large confluence of factors.[citation needed]

Melatonin activity

It has been suggested that a hypersensitivity of the melatonin receptors in the eye could be a reliable indicator of bipolar disorder, in studies called a trait marker, as it is not dependent on state (mood, time, etc). In small studies, patients diagnosed as bipolar reliably showed a melatonin-receptor hypersensitivity to light during sleep, causing a rapid drop in sleeptime melatonin levels compared to controls.[127] Another study showed that drug-free, recovered, bipolar patients exhibited no hypersensitivity to light.[128] It has also been shown in humans that valproic acid, a mood stabilizer, increases transcription of melatonin receptors[129] and decreases eye melatonin-receptor sensitivity in healthy volunteers[130] while low-dose lithium, another mood stabilizer, in healthy volunteers, decreases sensitivity to light when sleeping, but doesn't alter melatonin synthesis.[131] The extent to which melatonin alterations may be a cause or effect of bipolar disorder are not fully known.

Psychological processes

Psychological studies of bipolar disorder have examined the development of a wide range of both the core symptoms of psychomotor activation and related clusterings of depression/anxiety, increased hedonic tone, irritability/aggression and sometimes psychosis. The existing evidence has been described as patchy in terms of quality but converging in a consistent manner. The findings suggest that the period leading up to mania is often characterized by depression and anxiety at first, with isolated sub-clinical symptoms of mania such as increased energy and racing thoughts. The latter increase and lead to increased activity levels, the more so if there is disruption in circadian rhythms or goal attainment events. There is some indication that once mania has begun to develop, social stressors, including criticism from significant others, can further contribute. There are also indications that individuals may hold certain beliefs about themselves, their internal states, and their social world (including striving to meet high standards despite it causing distress) that may make them vulnerable during changing mood states in the face of relevant life events. In addition, subtle frontal-temporal and subcortical difficulties in some individuals, related to planning, emotional regulation and attentional control, may play a role. Symptoms are often subthreshold and likely continuous with normal experience. Once (hypo)mania has developed, there is an overall increase in activation levels and impulsivity. Negative social reactions or advice may be taken less notice of, and a person may be more caught up in their own thoughts and interpretations, often along a theme of feeling criticised. There is some suggestion that the mood variation in bipolar disorder may not be cyclical as often assumed, nor completely random, but results from a complex interaction between internal and external variables unfolding over time; there is mixed evidence as to whether relevant life events are found more often in early than later episodes.[28] Many sufferers report inexplicably varied cyclical patterns, however.[132]

Pharmaceutical Treatment

There are a number of pharmacological and psychotherapeutic techniques used for Bipolar Disorder. Individuals may use self-help and pursue a personal recovery journey.

Hospitalization may occur, especially with manic episodes. This can be voluntary or (if mental health legislation allows it) involuntary (called civil or involuntary commitment). Long-term inpatient stays are now less common due to deinstitutionalization, although can still occur.[133] Following (or in lieu of) a hospital admission, support services available can include drop-in centers, visits from members of a community mental health team or Assertive Community Treatment team, supported employment and patient-led support groups.[134]

Medication

Sodium valproate is a common mood stabilizer

The mainstay of treatment is a mood stabilizer medication such as lithium carbonate or lamotrigine. There is an evidence based review [135][136] which shows these two drugs are the most effective. Lamotrigine has been found to be best for preventing depressions, while lithium is the only drug proven to reduce suicide in bipolar patients. These two drugs comprise several unrelated compounds which have been shown to be effective in preventing relapses of manic, or in the one case, depressive episodes. The first known and "gold standard" mood stabilizer is lithium,[137] while almost as widely used is sodium valproate,[138] also used as an anticonvulsant. Other anticonvulsants used in bipolar disorder include carbamazepine, reportedly more effective in rapid cycling bipolar disorder, and lamotrigine, which is the first anticonvulsant shown to be of benefit in bipolar depression.[139]

Treatment of the agitation in acute manic episodes has often required the use of atypical antipsychotic medications, such as quetiapine, olanzapine and chlorpromazine. More recently, olanzapine and quetiapine have been approved as effective monotherapy for the maintenance of bipolar disorder.[140] A head-to-head randomized control trial in 2005 has also shown olanzapine monotherapy to be as effective and safe as lithium in prophylaxis.[141]

The use of antidepressants in bipolar disorder has been debated, with some studies reporting a worse outcome with their use triggering manic, hypomanic or mixed episodes, especially if no mood stabiliser is used. However, most mood stabilizers are of limited effectiveness in depressive episodes. Rapid cycling can be induced or made worse by antidepressants, unless there is adjunctive treatment with a mood stabilizer.[142][143] One large-scale study found that depression in bipolar disorder responds no better to an antidepressant with mood stabilizer than it does to a mood stabilizer alone.[144] Recent research indicates that triacetyluridine may help improve symptoms of bipolar disorder. [145]

Also, topiramate is an anticonvulsant often prescribed as a mood stabilizer. It is an off-label use when used to treat bipolar disorder. Unfortunately, it's efficacy is likely minimal and side effects, such as significant cognitive impairment, limit its usefulness (Kushner, et al. 2006 Bipolar Disorders 8; Chengappa, et al. 2006 J Clin Psych; 6).

When medication causes a reduction in symptoms or complete remission, it is important for someone with a bipolar disorder to understand they should continue to take the medicine. This can be complicated, as effective treatment may result in the reduction of manic symptoms and/or the medicine can be mood blunting or sedative, resulting in the person feeling they are stifled or that the medicine isn't working. Either way, relapse is likely to occur if the medicine is discontinued.

Psychosocial Treatment

Psychotherapy is aimed at alleviating core symptoms, recognizing episode triggers, reducing negative expressed emotion in relationships, recognizing prodromal symptoms before full-blown recurrence, and, practicing the factors that lead to maintenance of remission[146] Cognitive behavioural therapy, family-focused therapy, and psychoeducation have the most evidence for efficacy in regard to relapse prevention, while interpersonal and social rhythm therapy and cognitive-behavioural therapy appear the most effective in regard to residual depressive symptoms. Most studies have been based only on bipolar I, however, and treatment during the acute phase can be a particular challenge.[147] Some clinicians emphasize the need to talk with individuals experiencing mania, to develop a therapeutic alliance in support of recovery.[148]

Prognosis

For many individuals with bipolar disorder a good prognosis results from good treatment, which, in turn, results from an accurate diagnosis. Because bipolar disorder can have a high rate of both under-diagnosis and misdiagnosis[citation needed], it is often difficult for individuals with the condition to receive timely and competent treatment.

Bipolar disorder can be a severely disabling medical condition. However, many individuals with bipolar disorder can live full and satisfying lives. Quite often, medication is needed to enable this. Persons with bipolar disorder are likely to have periods of normal or near normal functioning between episodes.

Ultimately one's prognosis depends on many factors, several of which are within the control of the individual. Such factors may include: the right medicines, with the right dose of each; comprehensive knowledge of the disease and its effects; a positive relationship with a competent medical doctor and therapist; and good physical health, which includes exercise, nutrition, and a regulated stress level.

There are obviously other factors that lead to a good prognosis as well, such as being very aware of small changes in one's energy, mood, sleep and eating behaviors, as well as having a plan in conjunction with one's doctor for how to manage subtle changes that might indicate the beginning of a mood swing. Some people find that keeping a log of their moods can assist them in predicting changes.[149]

Functioning

A recent 20-year prospective study on bipolar I and II found that functioning varied over time along a spectrum from good to fair to poor. During periods of major depression or mania (in BPI), functioning was on average poor, with depression being more persistently associated with disability than mania. Functioning between episodes was on average good — more or less normal. Subthreshold symptoms were generally still substantially impairing, however, except for hypomania (below or above threshold) which was associated with improved functioning.[150]

Another study confirmed the seriousness of the disorder as "the standardized all-cause mortality ratio among patients with BD is increased approximately two-fold." Bipolar disorder is currently regarded "as possibly the most costly category of mental disorders in the United States." Episodes of abnormality are associated with distress and disruption, and an elevated risk of suicide, especially during depressive episodes. [151]

Recovery

A naturalistic study from first admission for mania or mixed episode (representing the hospitalized and therefore most severe cases) found that 50% achieved syndromal recovery (no longer meeting criteria for the diagnosis) within six weeks and 98% within two years. 72% achieved symptomatic recovery (no symptoms at all) and 43% achieved functional recovery (regaining of prior occupational and residential status). However, 40% went on to experience a new episode of mania or depression within 2 years of syndromal recovery, and 19% switched phases without recovery.[152]

Recurrence

The following behaviors can lead to depressive or manic recurrence:[citation needed]

  • Discontinuing or lowering one's dose of medication.
  • Being under- or over-medicated. Generally, taking a lower dosage of a mood stabilizer can lead to relapse into mania. Taking a lower dosage of an antidepressant may cause the patient to relapse into depression, while higher doses can cause destabilization into mixed-states or mania.
  • An inconsistent sleep schedule can destabilize the illness. Too much sleep (possibly caused by medication) can lead to depression, while too little sleep can lead to mixed states or mania.
  • Caffeine can cause destabilization of mood toward irritability, dysphoria, and mania. Anecdotal evidence seems to suggest that lower dosages of caffeine can have effects ranging from anti-depressant to mania-inducing.
  • Inadequate stress management and poor lifestyle choices. If unmedicated, excessive stress can cause the individual to relapse. Medication raises the stress threshold somewhat, but too much stress still causes relapse.
  • Often bipolar individuals are subject to self-medication, the most common drugs being alcohol, and marijuana. Studies show that tobacco smoking induces a calming effect on most bipolar people, and a very high percentage suffering from the prolonged use.[153]

Recurrence can be managed by the sufferer with the help of a close friend, based on the occurrence of idiosyncratic prodromal events.[154] This theorizes that a close friend could notice which moods, activities, behaviours, thinking processes, or thoughts typically occur at the outset of bipolar episodes. They can then take planned steps to slow or reverse the onset of illness, or take action to prevent the episode from being damaging.[155] These sensitivity triggers show some similarity to traits of a highly sensitive person.

Mortality

According to an article in Psychiatric Times by McIntyre et al., "Mortality studies have documented an increase in all-cause mortality in patients with BD. A newly established and rapidly growing database indicates that mortality due to chronic medical disorders (eg, cardiovascular disease) is the single largest cause of premature and excess deaths in BD. The standardized mortality ratio from suicide in BD is estimated to be approximately 18 to 25, further emphasizing the lethality of the disorder."[156]

Although many people with bipolar disorder who attempt suicide never actually complete it, the annual average suicide rate in males and females with diagnosed bipolar disorder (0.4%) is 10 to more than 20 times that in the general population.[157]

Individuals with bipolar disorder may become suicidal, especially during mixed states such as dysphoric mania and agitated depression.[158] Persons suffering from Bipolar II have high rates of suicide compared to persons suffering from other mental health conditions, including Major Depression. Major Depressive episodes are part of the Bipolar II experience, and there is evidence that sufferers of this disorder spend proportionally much more of their life in the depressive phase of the illness than their counterparts with Bipolar I Disorder (Akiskal & Kessler, 2007[which?]).

History

Varying moods and energy levels have been a part of the human experience since time immemorial. The words "melancholia" (an old word for depression) and "mania" have their etymologies in Ancient Greek. The word melancholia is derived from melas/μελας, meaning "black", and chole/χολη, meaning "bile" or "gall",[159] indicative of the term’s origins in pre-Hippocratic humoral theories. Within the humoral theories, mania was viewed as arising from an excess of yellow bile, or a mixture of black and yellow bile. The linguistic origins of mania, however, are not so clear-cut. Several etymologies are proposed by the Roman physician Caelius Aurelianus, including the Greek word ‘ania’, meaning to produce great mental anguish, and ‘manos’, meaning relaxed or loose, which would contextually approximate to an excessive relaxing of the mind or soul (Angst and Marneros 2001). There are at least five other candidates, and part of the confusion surrounding the exact etymology of the word mania is its varied usage in the pre-Hippocratic poetry and mythologies (Angst and Marneros 2001).

The idea of a relationship between mania and melancholia can be traced back to at least the 2nd century AD. Soranus of Ephesus (98–177 AD) described mania and melancholia as distinct diseases with separate etiologies;[160] however, he acknowledged that “many others consider melancholia a form of the disease of mania” (Cited in Mondimore 2005 p.49).

A clear understanding of bipolar disorder as a mental illness was recognized by early Chinese authors. The encyclopedist Gao Lian (c. 1583) describes the malady in his Eight Treatises on the Nurturing of Life (Ts'un-sheng pa-chien).[161]

The earliest written descriptions of a relationship between mania and melancholia are attributed to Aretaeus of Cappadocia. Aretaeus was an eclectic medical philosopher who lived in Alexandria somewhere between 30 and 150 AD (Roccatagliata 1986[which?]; Akiskal 1996[which?]). Aretaeus is recognized as having authored most of the surviving texts referring to a unified concept of manic-depressive illness, viewing both melancholia and mania as having a common origin in ‘black bile’ (Akiskal 1996[which?]; Marneros 2001[which?]).

Avicenna, a Persian physician and psychological thinker who wrote The Canon of Medicine in 1025, identified bipolar disorder as a manic depressive psychosis, which he clearly distinguished from other forms of madness (Junun) such as mania, rabies, and schizophrenia (Junun Mufrit or severe madness).[162]

Emil Kraepelin (1856–1926) refined the concept of psychosis.

The basis of the current conceptualisation of manic-depressive illness can be traced back to the 1850s; on January 31, 1854, Jules Baillarger described to the French Imperial Academy of Medicine a biphasic mental illness causing recurrent oscillations between mania and depression, which he termed folie à double forme (‘dual-form insanity’). [163] Two weeks later, on February 14, 1854, Jean-Pierre Falret presented a description to the Academy on what was essentially the same disorder, and designated folie circulaire (‘circular insanity’) by him.(Sedler 1983) The two bitterly disputed as to who had been the first to conceptualise the condition.

These concepts were developed by the German psychiatrist Emil Kraepelin (1856–1926), who, using Kahlbaum's concept of cyclothymia,[164] categorized and studied the natural course of untreated bipolar patients. He coined the term manic depressive psychosis, after noting that periods of acute illness, manic or depressive, were generally punctuated by relatively symptom-free intervals where the patient was able to function normally.[165]

After World War II, Dr. John Cade, an Australian psychiatrist, was investigating the effects of various compounds on veteran patients with manic depressive psychosis. In 1949, Cade discovered that lithium carbonate could be used as a successful treatment of manic depressive psychosis.[166] Because there was a fear that table salt substitutes could lead to toxicity or death, Cade's findings did not immediately lead to treatments. In the 1950s, U.S. hospitals began experimenting with lithium on their patients. By the mid-'60s, reports started appearing in the medical literature regarding lithium's effectiveness. The U.S. Food and Drug Administration did not approve of lithium's use until 1970.[167]

The term "manic-depressive reaction" appeared in the first American Psychiatric Association Diagnostic Manual in 1952, influenced by the legacy of Adolf Meyer who had introduced the paradigm illness as a reaction of biogenetic factors to psychological and social influences.[168] Subclassification of bipolar disorder was first proposed by German psychiatrist Karl Leonhard in 1957; he was also the first to introduce the terms bipolar (for those with mania) and unipolar (for those with depressive episodes only).[169]

In 1968, both the newly revised classification systems ICD-8 and DSM-II termed the condition "manic-depressive illness" as biological thinking came to the fore.[170]

The current nosology, bipolar disorder, became popular only recently, and some individuals prefer the older term because it provides a better description of a continually changing multi-dimensional illness.[citation needed]

Empirical and theoretical work on bipolar disorder has throughout history "seesawed" between psychological and biological ways of understanding. Despite the work of Kraepelin (1921) emphasizing the psychosocial context, conceptions of bipolar disorder as a genetically based illness dominated the 20th century. Since the 1990s, however, there has been a resurgence of interest and research in to the role of psychosocial processes.[117]

Sociological and cultural aspects

Cultural references

Kay Redfield Jamison is a clinical psychologist and Professor of Psychiatry at the Johns Hopkins University School of Medicine, who profiled her own bipolar disorder in her 1995 memoir An Unquiet Mind,[171] and argued for a connection between bipolar disorder and artistic creativity in her 1993 book, Touched with Fire.[172]

Several films portrayed characters with traits suggestive of the diagnosis which have been the subject of discussion by psychiatrists and film experts alike. The 1993 film Mr. Jones is a notable example, with Richard Gere playing a person who swings from a manic episode into a depressive phase and back again, spending time in a psychiatric hospital and displaying many of the features of the syndrome.[173] Allie Fox, the character played by Harrison Ford in the 1986 movie The Mosquito Coast, displays some features including recklessness, grandiosity, increased goal-directed activity and mood lability, as well as some paranoia.[174]

Tom Wilkinson portrayed a manic depressive lawyer in Tony Gilroy's film Michael Clayton.

Next to Normal, a rock musical debuted off-Broadway in 2008 before going on to play in Arlington, VA and eventually, in April 2009, on Broadway. Its story concerns a mother who struggles with worsening bipolar disorder and the effect that her illness has on her family.

In the Australian TV drama Stingers, Gary Sweet played the role of Detective Luke Harris from season six, portraying him as having bipolar and how the paranoia he feels as a result of it interferes with his work. As research for the role Sweet visited a psychiatrist to learn about manic depression. He said that he left the sessions convinced he was one.

TV specials, for example the BBC's The Secret Life of the Manic Depressive,[175] MTV's True Life: I'm Bipolar, talk shows, and public radio shows, and the greater willingness of public figures to discuss their own bipolar disorder, have focused on psychiatric conditions thereby raising public awareness.

On April 7, 2009, the nighttime drama 90210 on the CW network, aired a special episode where one of the characters, Silver, was diagnosed with bipolar disorder. A PSA aired after the episode, directing teens and young adults with questions or concerns about mood disorders to the Child and Adolescent Bipolar Foundation website for information, and to chat with other teens [176].

Recently Stacey Slater from the popular BBC soap EastEnders has begun to show signs of bipolar disorder; her mother Jean Slater also has bipolar disorder.[177]

References

  1. ^ http://linkinghub.elsevier.com/retrieve/pii/S0165032702004627
  2. ^ http://www.mental-health-matters.com/articles/article.php?artID=1176
  3. ^ http://www.nimh.nih.gov/health/publications/bipolar-disorder/what-are-the-symptoms-of-bipolar-disorder.shtml
  4. ^ Kessler, RC; Chiu WT, Demler O, Walters EE (2005). "Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R)". Arch Gen Psychiat 6: 617–27. PMID 15939839. http://archpsyc.ama-assn.org/cgi/content/full/62/6/617. 
  5. ^ Frederick K Goodwin and Kay R Jamison.Manic-Depressive Illness Chapter 7, "Epidemiology". Oxford University Press, 1990. ISBN 0195039343.
  6. ^ "Bipolar Disorder: Signs and symptoms". Mayo Clinic. http://www.mayoclinic.com/health/bipolar-disorder/DS00356/DSECTION=2. 
  7. ^ NIMH · Bipolar Disorder · Complete Publication
  8. ^ NIMH · Bipolar Disorder · Complete Publication
  9. ^ http://www.pueblo.gsa.gov/cic_text/health/bipolar/bipolar.htm
  10. ^ "Bipolar Disorder: Complications". Mayo Clinic. http://www.mayoclinic.com/health/bipolar-disorder/DS00356/DSECTION=7. 
  11. ^ Bergen M (1999). Riding the Roller Coaster: Living with Mood Disorders. Wood Lake Publishing Inc.. ISBN 9781896836317. 
  12. ^ Pope HG (1983). "Distinguishing bipolar disorder from schizophrenia in clinical practice: guidelines and case reports". Hospital and Community Psychiatry 34: 322–28. 
  13. ^ Goodwin & Jamison. pp. 108–110.
  14. ^ Akiskal HS, Yerevanian BI, Davis GC, King D, Lemmi H (February 1985). "The nosologic status of borderline personality: clinical and polysomnographic study". Am J Psychiatry 142 (2): 192–8. PMID 3970243. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=3970243. 
  15. ^ Gunderson JG, Elliott GR (1985). "The interface between borderline personality disorder and affective disorder". Am J Psychiatry 142: 277–288. 
  16. ^ McGlashan, TH (1983). "The borderline syndrome:Is it a variant of schizophrenia or affective disorder?". Arch Gen Psychiatry 40: 1319–1323. 
  17. ^ Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Gunderson JG (1983). "The validity of DSM-III borderline personality disorder: A phenomenologic, family history, treatment response, and long term follow up study". Arch Gen Psychiatry 40: 23–30. 
  18. ^ Psychiatric Times. Clinically Useful Psychiatric Scales: Bipolar Spectrum Diagnostic Scale, Accessed on March 9, 2009.
  19. ^ Ghaemi N. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. 2005;84:273-277.
  20. ^ Akiskal HS, Benazzi F (May 2006). "The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum". J Affect Disord. 92 (1): 45–54. doi:10.1016/j.jad.2005.12.035. PMID 16488021. 
  21. ^ Kessler, RC; McGonagle, KA; Zhao, S; Nelson, CB; Hughes, M; Eshleman, S; Wittchen, HU; Kendler, KS (1994), "Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States", Archives of General Psychiatry 51 (1): 8–19, doi:10.1001/archpsyc.51.1.8 (inactive 2008-06-25), PMID 8279933, http://archpsyc.ama-assn.org/cgi/content/abstract/51/1/8 
  22. ^ Angst, J; Selloro, R (September 15, 2000), "Historical perspectives and natural history of bipolar disorder", Biological Psychiatry 48 (6): 445–457, doi:10.1016/S0006-3223(00)00909-4 
  23. ^ Mackin, P; Young, AH (2004), "Rapid cycling bipolar disorder: historical overview and focus on emerging treatments", Bipolar Disorders 6 (6): 523–529, doi:10.1111/j.1399-5618.2004.00156.x 
  24. ^ Papolos, DF; Veit, S; Faedda, GL; Saito, T; Lachman, HM (1998), "Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele", Molecular Psychiatry 3 (4): 346–349, doi:10.1038/sj.mp.4000410, http://www.nature.com/mp/journal/v3/n4/abs/4000410a.html 
  25. ^ S. Nassir Ghaemi (2001). "Bipolar Disorder: How long does it usually take for someone to be diagnosed for bipolar disorder?". http://www.familyaware.org/expertprofiles/drghaemi4.asp. Retrieved on 2007-02-20. 
  26. ^ Roy H. Perlis (2005). "Misdiagnosis of Bipolar Disorder". http://www.ajmc.com/Article.cfm?Menu=1&ID=2969. Retrieved on 2007-02-20. 
  27. ^ Hypomanic Check List Questionnaire (HCL-32)
  28. ^ a b c Mansell, W. & Pedley, R. The ascent into mania: A review of psychological processes associated with the development of manic symptoms. Clinical Psychology Review, Volume 28, Issue 3, March 2008, Pages 494-520 PMID 17825463
  29. ^ Depression and Bipolar Support Alliance: About Mood Disorders
  30. ^ Goodwin & Jamison, 1990.
  31. ^ Sagman D and Tohen M (2009). "Comorbidity in Bipolar Disorder: The Complexity of Diagnosis and Treatment". Psychiatric Times. http://www.psychiatrictimes.com/display/article/10168/1391541. 
  32. ^ Kranowitz, C.S. & Post, R., (1996). Ultra-rapid and ultradian cycling in bipolar affective illness. British Journal of Psychiatry, 168, 314–323.
  33. ^ Naomi A. Schapiro Bipolar Disorders in Children and Adolescents J Pediatr Health Care. 2005;19(3):131-141.
  34. ^ Bipolar labels for children stir concern - The Boston Globe
  35. ^ Trinh NH, Forester B (2007). "Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment". Psychiatric Times 24 (14). http://www.psychiatrictimes.com/bipolar-disorder/article/10168/54481. 
  36. ^ Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB. (2006) A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006 July;93(1-3):105-15. PMID 16677713
  37. ^ Torres IJ, Boudreau VG, Yatham LN. (2007) Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl. 2007;(434):17-26. PMID 17688459 (Note: The full text of this study discloses pharmaceutical company funding)
  38. ^ "["http://people.howstuffworks.com/mad-genius3.htm" Mad Genius]". HowStuffWorks. "http://people.howstuffworks.com/mad-genius3.htm". Retrieved on 2008-09-08. 
  39. ^ Jamison, K R, Touched with Fire, Free Press, 1993, pp 83 ff.
  40. ^ Goodwin, F, and Jamison, K R, Manic-Depressive Illness, Oxford University Press, 1990, p 353
  41. ^ Santosa et al. Enhanced creativity in bipolar disorder patients: A controlled study. J Affect Disord. 2006 November 23; PMID 17126406.
  42. ^ Rihmer et al. Creativity and mental illness. Psychiatr Hung. 2006;21(4):288–94. PMID 17170470.
  43. ^ Nowakowska et al. Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. J Affect Disord. 2005 March;85(1–2):207–15. PMID 15780691.
  44. ^ Johnson SL (February 2005). "Mania and dysregulation in goal pursuit: a review". Clin Psychol Rev 25 (2): 241–62. doi:10.1016/j.cpr.2004.11.002. PMID 15642648. 
  45. ^ Soldani, Federico; Sullivan P. F. Pedersen N. L. (April 2005). "Mania in the Swedish Twin Registry: criterion validity and prevalence". Australian and New Zealand of Psychiatry 39 (4): 235–43. doi:10.1111/j.1440–1614.2005.01559.x. PMID 15777359. 
  46. ^ Judd, Lewis L.; Hagop S. Akiskal (January 2003). "The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases". Journal of Affective Disorders 73 (1–2): 123–31. doi:10.1016/S0165-0327(02)00332-4. PMID 12507745. http://linkinghub.elsevier.com/retrieve/pii/S0165032702003324. 
  47. ^ Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry. May;64(5):543-52.
  48. ^ Phelps, J. (2006) Bipolar Disorder: Particle or Wave? DSM Categories or Spectrum Dimensions? Psychiatric Times
  49. ^ Christie KA, Burke JD Jr, Regier DA, Rae DS, Boyd JH, Locke BZ (1988). "(abstract) Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults". Am J Psychiatry 145: 971–975. http://www.ajp.psychiatryonline.org/cgi/content/abstract/145/8/971 (abstract). Retrieved on 2007-07-01. 
  50. ^ Goodwin & Jamison. p. 121.
  51. ^ American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition Text Revision (DSM-IV-TR). 1-943
  52. ^ World Health Organization (1979) International classification of diseases. 9th ed.
  53. ^ Kraepelin (1921) Manic-Depressive Insanity and Paranoia.
  54. ^ Loranger and Levine (1978) Age at onset of bipolar affective illness. Archives of General Psychiatry. 35 1345-1348
  55. ^ Goodwin and Redfield Jamison (1990) Childhood and Adolescence. Manic-Depressive Illness. 186-209
  56. ^ Anthony and Scott (1960) Manic-depressive psychosis in childhood. Journal of Child Psychology and Psychiatry. 1 53-72
  57. ^ Hudziak, Althoff, Rettew, Derks and Faraone (2005) The prevalence and genetic architecture of CBCL-juvenile bipolar disorder. Biological Psychiatry. 58 562-8
  58. ^ Lewinsohn, Klein and Seeley (1995) Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. Journal of the American Academy of Child and Adolescent Psychiatry. 34 454-463
  59. ^ Weller, Weller, Tucker and Fristad (1986) Mania in prepubertal children: Has it been underdiagnosed? Journal of Affective Disorders. 11 151-154
  60. ^ Wozniak, Biederman, Kiely, Ablon, Faraone, Mundy and Mennin (1995) Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry. 34 867-876
  61. ^ Wozniak, Biederman, Mundy, Mennin and Faraone (1995) A pilot family study of childhood-onset mania. Journal of the American Academy of Child and Adolescent Psychiatry. 34 1577-1583
  62. ^ Carlson, Bromet, Driessens, Mojtabai and Schwartz (2002) Age at onset, childhood psychopathology, and 2-year outcome in psychotic bipolar disorder. Am J Psychiatry. 159 307-9.
  63. ^ Meyer, Carlson, Wiggs, Martinez, Ronsaville, Klimes-Dougan, Gold and Radke-Yarrow (2004) A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder. Dev Psychopathol. 16 461-76
  64. ^ Biederman (2003) Pediatric bipolar disorder coming of age. Biological Psychiatry. 53 931-934
  65. ^ Biederman, Mick, Faraone, Spencer, Wilens and Wozniak (2003) Current concepts in the validity, diagnosis and treatment of paedatric bipolar disorder. International Journal of Neuropsychopharmacology. 6 293-300
  66. ^ Geller and Luby (1997) Child and adolescent bipolar disorder: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry. 36 1168-1176
  67. ^ Geller and Tillman (2005) Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria. Journal of Clinical Psychiatry. 66 Suppl 7 21-28
  68. ^ (2007) Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 46 107-125
  69. ^ Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. (September 2007) "National trends in the outpatient diagnosis and treatment of bipolar disorder in youth," Archives of General Psychiatry. 64(9):1032–9. PMID 17768268
  70. ^ National Institute of Health and Clinical Excellence (2006). National clinical pratice guidelines number 38: Bipolar disorder: the management of bipolar disorder in adults, children and adolescents in primary and secondary care. London: National Collaborating Centre for Mental Health.
  71. ^ Meyer TD, Koßmann-Böhm S, Schlottke PF. Do child psychiatrists in Germany diagnose bipolar disorders in children and adolescents? Result from a survey. Bipolar Disorders, 2004; 6: 426 – 431
  72. ^ Parry P, Furber G, Allison S. The paediatric bipolar hypothesis: the view from Australia and New Zealand. Child and Adolescent Mental Health. (in press)
  73. ^ Carlson G, Meyer S. Phenomenology and diagnosis of bipolar disorder in children, adolescents, and adults: Complexities and developmental issues Development and Psychopathology 2006; 18:939–969
  74. ^ Harris J. Child & adolescent psychiatry: the increased diagnosis of “juvenile bipolar disorder”: what are we treating? Psychiatr Serv 2005; 56: 529 – 531
  75. ^ McClellan J. Commentary: treatment guidelines for child and adolescent bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005; 44: 236-239
  76. ^ Laurel Williams. Mental health and children: Too often the system conspires to treat behavioural problems with pills. Los Angeles Times 14 Dec 2008 available at: http://www.latimes.com/news/opinion/commentary/la-oe-williams14-2008dec14,0,3774809.story
  77. ^ Bipolar Children: Cutting-edge controversy, insights and research. Childhood in America series. editor Sharna Olfman. 2007. Praeger press. Westport CT. http://www.amazon.com/Bipolar-Children-Cutting-Edge-Controversy-Childhood/dp/0275997308/ref=sr_1_11?ie=UTF8&s=books&qid=1245833103&sr=8-11
  78. ^ USATODAY.com - New antipsychotic drugs carry risks for children
  79. ^ Glahn, Bearden, Caetano, Fonseca, Najt, Hunter, Pliszka, Olvera and Soares (2005) Declarative memory impairment in pediatric bipolar disorder. Bipolar Disord. 7 546-54
  80. ^ McClure, Treland, Snow, Dickstein, Towbin, Charney, Pine and Leibenluft (2005) Memory and learning in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 44 461-9
  81. ^ Pavuluri, Schenkel, Aryal, Harral, Hill, Herbener and Sweeney (2006) Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients. Am J Psychiatry. 163 286-93
  82. ^ Biederman, Kwon, Wozniak, Mick, Markowitz, Fazio and Faraone (2004) Absence of gender differences in pediatric bipolar disorder: Findings from a large sample of referred youth. Journal of Affective Disorders. 83 207-214
  83. ^ Caetano, Olvera, Hunter, Hatch, Najt, Bowden, Pliszka and Soares (2006) Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients. J Affect Disord. 91 33-7
  84. ^ Wozniak, Biederman, Kiely, Ablon and Faraone (1993) Prepubertal mania revisited. Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry
  85. ^ Wozniak, Biederman, Kiely, Ablon, Faraone, Mundy and Mennin (1995) Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry. 34 867-876
  86. ^ Wozniak, Biederman, Mundy, Mennin and Faraone (1995) A pilot family study of childhood-onset mania. Journal of the American Academy of Child and Adolescent Psychiatry. 34 1577-1583
  87. ^ Caetano, Olvera, Hunter, Hatch, Najt, Bowden, Pliszka and Soares (2006) Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients. J Affect Disord. 91 33-7
  88. ^ Wozniak, Biederman, Kiely, Ablon and Faraone (1993) Prepubertal mania revisited. Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry
  89. ^ Wozniak, Biederman, Kiely, Ablon, Faraone, Mundy and Mennin (1995) Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry. 34 867-876
  90. ^ Wozniak, Biederman, Mundy, Mennin and Faraone (1995) A pilot family study of childhood-onset mania. Journal of the American Academy of Child and Adolescent Psychiatry. 34 1577-1583
  91. ^ http://hbcg.vivadnn.com/Articles-Interviews/Bipolar-Phases.aspx Bipolar Phases in Children
  92. ^ Goldstein, Birmaher, Axelson, Ryan, Strober, Gill, Valeri, Chiappetta, Leonard, Hunt, Bridge, Brent and Keller (2005) History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. 7 525-35
  93. ^ Depp CA, Jeste DV. (2004) Bipolar disorder in older adults: a critical review Bipolar Disord. 2004 October;6(5):343-67.
  94. ^ Kieseppä T, Partonen T, Haukka J, Kaprio J, Lönnqvist J (October 2004). "High concordance of bipolar I disorder in a nationwide sample of twins". Am J Psychiatry 161 (10): 1814–21. doi:10.1176/appi.ajp.161.10.1814. PMID 15465978. 
  95. ^ a b Edvardsen J, Torgersen S, Røysamb E, Lygren S, Skre I, Onstad S, Oien PA. (2008) Heritability of bipolar spectrum disorders. Unity or heterogeneity? J Affect Disord. 2008 March;106(3):229-40. PMID 17692389
  96. ^ McGuffin, P; Rijsdijk, F; Andrew, M; Sham, P; Katz, R; Cardno, A (2003), "The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression", Archives of General Psychiatry 60 (5): 497–502, doi:10.1001/archpsyc.60.5.497, PMID 12742871, http://archpsyc.ama-assn.org/cgi/content/abstract/60/5/497 
  97. ^ Kato, T. (2007). "Molecular genetics of bipolar disorder and depression." Psychiatry Clin Neurosci 61(1): 3-19. PMID 17239033
  98. ^ Reich, T., P. J. Clayton and G. Winokur (1969). "Family history studies-V The genetics of Mania." American Journal of Psychiatry l25: l358-1369.
  99. ^ a b Margit Burmeister, Melvin G. McInnis, & Sebastian Zöllner Psychiatric genetics: progress amid controversy Nature Reviews Genetics 9, 527-540 (July 2008) | doi:10.1038/nrg2381
  100. ^ Barden N., Harvey M., Gagne B., Shink E., Tremblay M., Raymond C., Labbe M., Villeneuve A., Rochette D., Bordeleau L., Stadler H., Holsboer F., and Muller-Myhsok B. (2006). "Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder." Am J Med Genet B Neuropsychiatr Genet.
  101. ^ Baum, A.E., et al. (2008). A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder Molecular Psychiatry, 13(2), 197-207. DOI: 10.1038/sj.mp.4002012
  102. ^ Burton, P.R., et al. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature, 447(7145), 661-678. DOI: 10.1038/nature05911
  103. ^ Sklar, P., J. W. Smoller, J. Fan, M. A. Ferreira, R. H. Perlis, K. Chambert et al. (2008). Whole-genome association study of bipolar disorder Molecular Psychiatry DOI: 10.1038/sj.mp.4002151
  104. ^ Ferreira, M., M. O’Donovan, Y. A. Meng, A. Jones I, D. M. Ruderfer1, L. Jones et al. (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder Nature Genetics 40, 1056–1058
  105. ^ Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, Craddock N, et al. (2003) Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder. Am J Hum Genet. 73, 49-62. PMID 12802785
  106. ^ McQuillin, A., N. J. Bass, G. Kalsi, J. Lawrence, V. Puri, K. Choudhury, S. D. Detera-Wadleigh, D. Curtis and H. M. Gurling (2006). "Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3." Mol Psychiatry 11(2): 134-142
  107. ^ Xu, C., F. Macciardi, P. P. Li, I. S. Yoon, R. G. Cooke, B. Hughes, S. V. Parikh, R. S. McIntyre, J. L. Kennedy and J. J. Warsh (2006). "Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder." Am J Med Genet B Neuropsychiatr Genet 141(1): 36-43.
  108. ^ Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Alexander M, Shaw SH, Kelsoe JR. (May 2003). "Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder". Molecular Psychiatry 8 (5): 546–57. doi:10.1038/sj.mp.4001268. http://www.nature.com/mp/journal/v8/n5/abs/4001268a.html. 
  109. ^ Zandi PP, Belmonte PL, Willour VL, et al. (July 2008). "Association study of Wnt signaling pathway genes in bipolar disorder". Arch. Gen. Psychiatry 65 (7): 785–93. doi:10.1001/archpsyc.65.7.785. PMID 18606951. http://archpsyc.ama-assn.org/cgi/content/full/65/7/785. 
  110. ^ Emma Young (2006). "New gene linked to bipolar disorder". New Scientist. http://www.newscientist.com/article.ns?id=dn8572&feedId=online-news_rss20. Retrieved on 2006. 
  111. ^ Frans, E., Sandin, S., Reichenberg, A., Lichtenstein, P., Langstrom, N., Hultman, C. (2008) Advancing Paternal Age and Bipolar Disorder Arch Gen Psychiatry. 2008;65(9):1034-1040.
  112. ^ a b Serretti A & Mandelli L. (2008) The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions. Mol Psychiatry. 2008 August;13(8):742-71. PMID 18332878
  113. ^ a b David J. Miklowitz and Kiki D. Chan Prevention of Bipolar Disorder in At-Risk Children: Theoretical Assumptions and Empirical Foundations Dev Psychopathol. Dev Psychopathol. 2008; 20(3): 881–897. doi: 10.1017/S0954579408000424.
  114. ^ Ross RG (July 2006). "Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder". Am J Psychiatry 163 (7): 1149–52. doi:10.1176/appi.ajp.163.7.1149. PMID 16816217. http://ajp.psychiatryonline.org/cgi/content/full/163/7/1149. 
  115. ^ DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM (April 2001). "Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset". Bipolar Disord 3 (2): 53–7. PMID 11333062. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1398-5647&date=2001&volume=3&issue=2&spage=53. 
  116. ^ Soutullo CA, DelBello MP, Ochsner JE, et al. (August 2002). "Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment". J Affect Disord 70 (3): 323–7. PMID 12128245. http://linkinghub.elsevier.com/retrieve/pii/S0165032701003366. 
  117. ^ a b Alloy LB, Abramson LY, Urosevic S, Walshaw PD, Nusslock R, Neeren AM. (2005) The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors. Clin Psychol Rev. 2005 December;25(8):1043-75. PMID 16140445
  118. ^ Gabriele S Leverich a, Robert M Post Course of bipolar illness after history of childhood trauma The Lancet, Volume 367, Issue 9516, Pages 1040 - 1042, 1 April 2006 doi:10.1016/S0140-6736(06)68450-XCite
  119. ^ Louisa D. Grandin, Lauren B. Alloy, Lyn Y. Abramson (2007) Childhood Stressful Life Events and Bipolar Spectrum Disorders Journal of Social and Clinical Psychology, 26 (4) pp460-478 doi: 10.1521/jscp.2007.26.4.460
  120. ^ Strakowski, S.M., DelBello, M.P, Sax, K.W. et al. (1999). "Brain magnetic resonance imaging of structural abnormalities in bipolar disorder," Archives of General Psychiatry, 56:254–60.
  121. ^ Prefrontal Cortex in Bipolar Disorder Neurotransmitter.net.
  122. ^ Kempton, M.J., Geddes, J.R, Ettinger, U. et al. (2008). "Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder," Archives of General Psychiatry, 65:1017–1032 see also MRI database at www.bipolardatabase.org.
  123. ^ Link and reference involving kindling theory
  124. ^ Brian Koehler, Ph.D., The International Society for the Psychological Treatment Of Schizophrenia and Other Psychoses, Bipolar Disorder, Stress, and the HPA Axis, 2005.
  125. ^ Stork C, Renshaw PF (July 2005). "Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research". Molecular Psychiatry 10: 900-919. doi:10.1038/sj.mp.4001711. PMID 13594184. 
  126. ^ Malcomb R. Brown; Michael R. Basso (2004). Focus on Bipolar Disorder Research. Nova Science Publishers. pp. 16. ISBN 978-1594540592. 
  127. ^ Lewy AJ, Nurnberger JI, Wehr TA, et al. (June 1985). "Supersensitivity to light: possible trait marker for manic-depressive illness". Am J Psychiatry 142 (6): 725–7. PMID 4003592. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=4003592. 
  128. ^ Whalley LJ, Perini T, Shering A, Bennie J (July 1991). "Melatonin response to bright light in recovered, drug-free, bipolar patients". Psychiatry Res 38 (1): 13–9. PMID 1658841. 
  129. ^ Castro LM, Gallant M, Niles LP (December 2005). "Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells". J. Neurochem. 95 (5): 1227–36. doi:10.1111/j.1471-4159.2005.03457.x. PMID 16313512. 
  130. ^ Hallam KT, Olver JS, Norman TR (July 2005). "Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers". Neuropsychopharmacology 30 (7): 1400–4. doi:10.1038/sj.npp.1300739. PMID 15841104. 
  131. ^ Hallam KT, Olver JS, Horgan JE, McGrath C, Norman TR (June 2005). "Low doses of lithium carbonate reduce melatonin light sensitivity in healthy volunteers". Int. J. Neuropsychopharmacol. 8 (2): 255–9. doi:10.1017/S1461145704004894. PMID 15850501. 
  132. ^ Manic-depressive illness FK Goodwin, KR Jamison - 1990 - Oxford University Press New York
  133. ^ Becker T, Kilian R. (2006) Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care? Acta Psychiatrica Scandinavica Supplement, 429, 9–16. PMID 16445476
  134. ^ McGurk, SR, Mueser KT, Feldman K, Wolfe R, Pascaris A (2007). Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry. March;164(3):437–41. PMID 17329468
  135. ^ Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217–22
  136. ^ Bauer, M.S. et al. 2006, What Is a “Mood Stabilizer”? An Evidence-Based Response, Am J Psychiatry 2004; 161:3–18
  137. ^ Poolsup N, Li Wan Po A, de Oliveira IR. (2000) Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 25: 139–156 PMID: 10849192
  138. ^ Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. (2002). "(abstract) Valproate for acute mood episodes in bipolar disorder". The Cochrane Database of Systematic Reviews (John Wiley and Sons, Ltd.) (2). doi:10.1002/14651858.CD004052. ISSN 1464-780X. http://www.cochrane.org/reviews/en/ab004052.html (abstract). 
  139. ^ Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (February 1999). "A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group". J Clin Psychiatry 60 (2): 79–88. PMID 10084633. 
  140. ^ Now Approved: ZYPREXA for maintenance therapy for bipolar disorder. Official Zyprexa Website.
  141. ^ Tohen M, Greil W, Calabrese JR, et al. (July 2005). "Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial". Am J Psychiatry 162 (7): 1281–90. doi:10.1176/appi.ajp.162.7.1281. PMID 15994710. 
  142. ^ "Treatment of refractory and rapid-cycling bipolar disorder". http://www.wpic.pitt.edu/stanley/1stbipconf/bipolar2.htm#trtref. 
  143. ^ Sachs, GS, MD, et al. (2007) Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression New England Journal of Medicine, Volume 356:1711–1722 (Abstract).
  144. ^ Bipolar surprise: mood disorder endures antidepressant setback. Science News, March 31, 2007, vol. 171, #13, p.196
  145. ^ http://www.epsychology.us/triacetyluridine-tau-decreases-depressive-symptoms-and-increases-brain-ph-in-bipolar-patients/
  146. ^ (Lam et al., 1999; Johnson & Leahy, 2004; Basco & Rush, 2005; Miklowitz & Goldstein, 1997; Frank, 2005.
  147. ^ Zaretsky AE, Rizvi S, & Parikh SV. (2007). How well do psychosocial interventions work in bipolar disorder? Can J Psychiatry, January;52(1):14-21.
  148. ^ Havens LL, Ghaemi SN. (2005) Existential despair and bipolar disorder: the therapeutic alliance as a mood stabilizer. Am J Psychother. 59(2):137-47 PMID 16170918
  149. ^ "Introduction". cs.umd.edu. http://www.cs.umd.edu/class/spring2004/cmsc434/teams/rise/Introduction.htm. Retrieved on 2008-02-16. 
  150. ^ Judd Lewis L.; Aksikal Hagop S.; Schettler Pamela J. ; Endicott Jean; Leon Andrew C.; Solomon David A.; Coryell William; Maser Jack D.; Keller Martin B. (2005) Psychosocial disability in the course of bipolar I and II disorders : A prospective, comparative, longitudinal study Archives of General Psychiatry, vol. 62, no12, pp. 1322–1330
  151. ^ Ösby, U; Brandt, L; Correia, N; Ekbom, A; Sparén, P (2001), "Excess Mortality in Bipolar and Unipolar Disorder in Sweden", Archives of General Psychiatry 58 (9): 844–850, doi:10.1001/archpsyc.58.9.844, PMID 11545667, http://archpsyc.ama-assn.org/cgi/content/abstract/58/9/844 
  152. ^ Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. (2003) The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence Am J Psychiatry. 2003 December;160(12):2099-107.
  153. ^ Bipolar Disorder webpage from ADAM Illustrated Health Encyclopedia at About.com
  154. ^ Perry A, Tarrier N, Morriss R, McCarthy E, Limb K (January 1999). "Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment". BMJ 318 (7177): 149–53. PMID 9888904. PMC: 27688. http://bmj.com/cgi/pmidlookup?view=long&pmid=9888904. 
  155. ^ Kelly, M., Bipolar and the Art of Roller-coaster Riding, Two Trees Media 2000, 2005
  156. ^ Roger S. McIntyre, MD, Joanna K. Soczynska, and Jakub Konarski. "Bipolar Disorder: Defining Remission and Selecting Treatment". Psychiatric Times, October 2006, Vol. XXIII, No. 11. http://www.psychiatrictimes.com/article/showArticle.jhtml?articleId=193400986. 
  157. ^ Leslie Citrome, MD, MPH; Joseph F. Goldberg, MD. "Bipolar disorder is a potentially fatal disease". http://www.postgradmed.com/issues/2005/02_05/comm_citrome.htm. 
  158. ^ Psychopathologic Correlates of Suicidal Ideation in Major Depressive Outpatients: Is It All Due to Unrecognized (Bipolar) Depressive Mixed States?
  159. ^ Liddell, Henry George and Robert Scott (1980). A Greek-English Lexicon (Abridged Edition). United Kingdom: Oxford University Press. ISBN 0-19-910207-4. 
  160. ^ "Bipolar_disorders_beyond_major_depression_and_euphoric_mania" (PDF). cambridge.org. http://assets.cambridge.org/97805218/35176/excerpt/9780521835176_excerpt.pdf. Retrieved on 2008-02-16. 
  161. ^ http://www.nmh.gov.tw/nmh_web/english_version/exhibition/exhibition_s0703.cfm
  162. ^ Youssef, Hanafy A.; Fatma A. Youssef & T. R. Dening (1996), "Evidence for the existence of schizophrenia in medieval Islamic society", History of Psychiatry 7: 55–62 [57]
  163. ^ "Circular insanity, 150 years on". http://www.ncbi.nlm.nih.gov/pubmed/15506718. Retrieved on 2008-04-12. 
  164. ^ Millon, Theordore (1996). Disorders of Personality: DSM-IV-TM and Beyond. New York: John Wiley and Sons. pp. 290. ISBN 0-471-01186-X. 
  165. ^ Kraepelin, Emil (1921) Manic-depressive Insanity and Paranoia ISBN 0-405-07441-7
  166. ^ Cade JF (September 1949). "Lithium salts in the treatment of psychotic excitement" (PDF). Med. J. Aust. 2 (10): 349–52. PMID 18142718. http://www.who.int/docstore/bulletin/pdf/2000/issue4/classics.pdf. 
  167. ^ Mitchell PB, Hadzi-Pavlovic D (2000). "Lithium treatment for bipolar disorder" (PDF). Bull. World Health Organ. 78 (4): 515–7. PMID 10885179. http://www.who.int/docstore/bulletin/pdf/2000/issue4/classics.pdf. 
  168. ^ Goodwin & Jamison. pp. 60–61.
  169. ^ Goodwin & Jamison. p62
  170. ^ Goodwin & Jamison. p88
  171. ^ Jamison, Kay Redfield (1995). An Unquiet Mind: A Memoir of Moods and Madness. New York: Knopf.. ISBN 0-330-34651-2. 
  172. ^ Jamison, Kay Redfield (1996). Touched With Fire: Manic-Depressive Illness and the Artistic Temperament. New York: The Free Press: Macmillian, Inc.. ISBN 0-684-83183-X. 
  173. ^ Robinson DJ (2003). Reel Psychiatry:Movie Portrayals of Psychiatric Conditions. Port Huron, Michigan: Rapid Psychler Press. pp. 78–81. ISBN 1-894328-07-8. 
  174. ^ Robinson (Reel Psychiatry:Movie Portrayals of Psychiatric Conditions), p. 84-85
  175. ^ "The Secret Life of the Manic Depressive". BBC. 2006. http://www.bbc.co.uk/health/tv_and_radio/secretlife_index.shtml. Retrieved on 2007-02-20. 
  176. ^ "Child and Adolescent Bipolar Foundation special 90210 website". CABF. 2009. http://www.bpkids.org/90210. Retrieved on 2009-04-07. 
  177. ^ "EastEnders' Stacey faces bipolar disorder". BBC Press Office. 2009-05-14. http://www.bbc.co.uk/pressoffice/pressreleases/stories/2009/05_may/14/stacey.shtml. Retrieved on 2009-05-28. 

Cited texts

  • Goodwin FK, Jamison KR (1990). Manic-Depressive Illness. New York: Oxford University Press. ISBN 0-19-503934-3. 
  • Goodwin FK, Jamison KR (2007). Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd Edition. New York: Oxford University Press. ISBN 0-19-513579-2. 

Further reading

Other contemporary first-person accounts on this subject include

To find out more about how to deal with bipolar first-hand or how friends and family can deal with it, see:

For readings regarding bipolar disorder in children, see:

  • Raeburn, Paul. 2004. Acquainted with the Night: A Parent's Quest to Understand Depression and Bipolar Disorder in His Children.
  • Earley, Pete. Crazy. 2006. New York: G. P. Putnam's Sons. ISBN 0-399-15313-6. A father's account of his son's bipolar disorder.

Classic works on this subject include

  • Kraepelin, Emil. 1921. Manic-depressive Insanity and Paranoia ISBN 0-405-07441-7 (English translation of the original German from the earlier eighth edition of Kraepelin's textbook — now outdated, but a work of major historical importance).
  • Mind Over Mood: Cognitive Treatment Therapy Manual for Clients by Christine Padesky, Dennis Greenberger. ISBN 0-89862-128-3

External links


 
 

 

Copyrights:

Medical Encyclopedia. © 2006 through a partnership of Answers Corporation. All rights reserved.  Read more
Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2007. Published by Houghton Mifflin Company. All rights reserved.  Read more
Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved.  Read more
Alternative Medicine Encyclopedia. Encyclopedia of Alternative Medicine. Copyright © 2005 by The Gale Group, Inc. All rights reserved.  Read more
Children's Health Encyclopedia. © 2006 through a partnership of Answers Corporation. All rights reserved.  Read more
Britannica Concise Encyclopedia. Britannica Concise Encyclopedia. © 2006 Encyclopædia Britannica, Inc. All rights reserved.  Read more
Columbia Encyclopedia. The Columbia Electronic Encyclopedia, Sixth Edition Copyright © 2003, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/  Read more
Health Dictionary. The New Dictionary of Cultural Literacy, Third Edition Edited by E.D. Hirsch, Jr., Joseph F. Kett, and James Trefil. Copyright © 2002 by Houghton Mifflin Company. Published by Houghton Mifflin. All rights reserved.  Read more
Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bipolar disorder" Read more